Bioresorbable scaffold: an integrated approach by Wang, Peijiang
Boston University
OpenBU http://open.bu.edu
































B.S., Shanghai Jiao Tong University, 2012 
B.S., University of Michigan, 2012 








Submitted in partial fulfillment of the 
 
requirements for the degree of 
 











































© 2018 by 
 PEIJIANG WANG 






First Reader   
 Elazer R. Edelman, M.D. Ph.D. 
 Edward J. Poitras Professor of Medical Engineering and 
Science 
 Massachusetts Institute of Technology 
 
 Professor of Medicine 
 Harvard University 
 
 
Second Reader   
 Bela Suki, Ph.D. 
 Professor of Biomedical Engineering 
 Professor of Materials Science and Engineering 
 
 
Third Reader   
 Joe Tien, Ph.D. 
 Associate Professor of Biomedical Engineering 
 Associate Professor of Materials Science and Engineering 
 
 
Fourth Reader   
 Dimitrije Stamenović, Ph.D. 
 Professor of Biomedical Engineering 
 Professor of Materials Science and Engineering 
 
 
Fifth Reader   
 Jeffrey C. Grossman, Ph.D. 
 Morton and Claire Goulder and Family Professor in 
Environmental Systems 
 Professor of Materials Science and Engineering 
 Massachusetts Institute of Technology 
 
 
Sixth Reader   
 Nicola Ferralis, Ph.D. 
 Research Scientist, Materials Science and Engineering 




This dissertation would not have been possible without the support from 
numerous individuals. Foremost, I would like to express my sincere gratitude to 
my advisor Dr. Elazer Edelman. As a student from Boston University, I did not 
expect his reply after sending an email asking for a research opportunity in his lab, 
yet he not only invited me to the lab for a discussion, but also offered me an 
opportunity to rotate in the lab and get to know everyone. My dissertation would 
not have been such successful without his unparalleled vision, translational 
perspectives, and most importantly, his selfless mentorship through countless 
reviews and rehearsals on each proposal, manuscript, and presentation. 
I am also fortunate to have a remarkable thesis committee, Dr. Bela Suki, 
Dr. Joe Tien, Dr. Dimitrije Stamenovic, Dr. Jeffrey Grossman, and Dr. Nicola 
Ferralis. Every member has been generous in providing time and suggestions that 
not only improved this work but also helped me develop a broader and deeper 
understanding on conducting integrated research. I would like to thank Dr. Jeffrey 
Grossman and Dr. Nicola Ferralis for their patience on guiding me to understand 
basic materials science. Dr. Bela Suki, Dr. Joe Tien, and Dr. Dimitrije Stamenovic 
provided in-depth knowledge on solid and fluid mechanics. With their exceptional 
insights, I have been able to bring all these different tools into the clinical spaces. 
This work could not have been achieved without the resources and help 
from Boston Scientific. I would like to thank Dr. Aparna Bhave, Dr. Andrew Bicek, 
 
 v 
and Dr. S. Omar Jobe for their supports on the completion of my dissertation. Dr. 
Dennis Boismier provided materials critical to the success of this project. Mr. Jesse 
Johnson helped us build the sophisticated high throughput multimodal tester. 
I would not have survived the life as a PhD student without the incredible 
support from all members of the Edelman Lab. It is an amazing experience to work 
with people all over the world with different expertise and cultural background. I 
would like to thank particularly my colleagues, Dr. Claire Conway and Dr. Farhad 
Rikhtegar Nezami for their insights on this project; Dr. Brian Chang for pushing me 
to defend earlier than planned; Efrat Goffer, Francesca Berti, Achille Verheye, and 
Ben Leiden for helping me go through the journey both in and out of the lab. I would 
also like to thank our collaborators for their tremendous help, Dr. Francesco 
Migliavacca and Dr. Lorenza Petrini from the Laboratory of Biological Structure 
Mechanics at Politecnico de Milano, and Dr. Tomasz Wierzbicki and Dr. Maysam 
Gorji from the Impact and Crashworthiness Laboratory at MIT. 
Finally, I want to thank my fiancée, Kehan Zhang, without whom I would not 
have been able to complete my Ph.D. Her supports, from the surprising tolerance 
for listening to presentations and reviewing countless drafts to inspiring 
suggestions and critics on my ideas, have made this work and my life complete. 
Last but not least, this work is dedicated to my parents, Mrs. Shuwen Xu and Mr. 
Zhenyong Wang who have always been supportive to all my decisions. None of 
my accomplishments would have been possible without their decades of support.  
 
 vi 




Boston University College of Engineering, 2018 
 
Major Professor: Elazer R. Edelman, M.D., Ph.D., Edward J. Poitras Professor of 
Medical Engineering and Science, Massachusetts Institute of 
Technology; Professor of Medicine, Harvard University  
 
ABSTRACT 
Bioresorbable scaffolds (BRS) were thought to represent the next 
cardiovascular interventional revolution in relief of obstructive coronary 
atherosclerosis, yet they failed in comparison to metal stents. They were expected 
to provide mechanical support non-inferior to metal stents in short-term and 
gradually degrade to eliminate long-term complications associated with permanent 
implants. However, their clinical performances at all times were inferior to metal 
stents, including increased rate of thrombosis and myocardial infraction. These 
problems evaded detection, emerging only in clinical trials, leading one to wonder 
if BRS were appropriately characterized during the preclinical testing. We 
specifically questioned whether methods designed for metal stents could detect 
issues with BRS or hide potential areas of concerns. 
This work sought to determine how to define mechanical failure modes of 
BRS distinct from metal stents, and if such definition might have predicted clinical 
failure of the 1st generation BRS and if implemented now enable optimization of 
the design of next generation scaffolds. 
 
 vii 
We developed a BRS-specific integrated approach involving benchtop 
mechanical testing, computational modelling, material characterization, and 
animal model validation evaluating de novo intact devices or those in which control 
defects were introduced. We performed mechanical characterizations with variable 
working environments and parameters. Micro-cracks and localized deformations 
were identified as a form of accelerated wear and challenge to structural integrity. 
We designed and built a high-throughput multimodal fatigue tester to generate 
deformation modes evident in arterial deformations in vivo, and test scaffold 
durability during acute and subacute timeframes. We reproduced fracture rates 
and locations seen in animal models, and revealed the relationship between 
loading modes, scaffold design, and fracture initiation and propagation. Finally, we 
utilized Raman spectroscopy to identify heterogeneities in material microstructures, 
which induced non-uniform degradation and severe localized deformations that 
could explain early structural failures and late clinical complications. 
Failure modes of BRS are distinct from those of bare metal stents and 
techniques designed to detect the one are not readily appropriate for the other. 
Characterization of device performance matched to device design might enable 
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CHAPTER ONE: INTRODUCTION AND MOTIVATION 
Bioresorbable materials have been widely used in clinical and scientific 
applications. They are designed to provide functions for a specific period of time 
and disappear thereafter with minimal residual effects. Such a paradigm is 
expected to overcome challenges confronted by permanent indwelling devices 
including inflammation from retained foreign bodies and fatigue-induced 
mechanical failure. Major applications of bioresorbable materials include surgery 
sutures, orthopedic implants, drug delivery systems, tissue regeneration scaffolds, 
and cardiovascular implants, specifically and most recently endovascular coronary 
stents. 
Endovascular coronary stents are used in treating coronary obstructive 
atherosclerosis, a chronic arterial disease in which the vessel wall thickens from 
the accumulation of lipids and white blood cells such as macrophages and 
lymphocytes in the vessel intima accompanied by the accumulation of extracellular 
matrix and proliferating smooth muscle cells 1. If untreated, atherosclerosis can 
narrow the vascular lumen area, preventing blood flow through vessels to tissues 
and organs, and potentially lead to complete vessel occlusion with clot and 
downstream embolization, vessel dilation or rupture, heart attack, kidney failure, 
limb ischemia, stroke and even death 1. Coronary atherosclerosis, as the most 
common type of heart disease, kills almost 400,000 people in the United States 




obesity, poor diet, hypertension and advanced age 3. Reopening or bypassing the 
diseased vessels or vessel segments are the main means proposed to treat 
obstructive atherosclerosis, and stent implantation via coronary angioplasty is 
currently one of the most frequently used techniques. 
 
1.1. Evolution in Coronary Angioplasty 
Coronary angioplasty is a minimally invasive technique to directly restore 
blood flow to narrowed or obstructed blood vessels. It was conceptually described 
by Dr. Charles T. Dotter and Dr. Melvin P. Judkins in 1964, and was first performed 
by Dr. Andreas Gruntzig in 1977 4. It revolutionized the treatment of coronary artery 
disease. The technique, which is now referred as plain old balloon angioplasty 
(POBA), utilizes a catheter with an inflatable balloon attached to its tip. The 
catheter is inserted via a peripheral blood vessel, usually femoral or radial artery, 
into the affected vessel. The balloon is inflated to open the lumen and then deflated 
to withdraw. The minimal invasiveness helps reducing the long hospitalization and 
post-surgical recovery times required in invasive surgeries such as coronary artery 
bypass grafting (CABG) 5. However, it was accompanied by an unacceptably high 
rate of acute vessel closure 6. This is due to a combination of elastic recoil, 
subintimal hemorrhage under the plaque, thrombus formation, intimal and medial 
dissection, neointimal hyperplasia, and constrictive vessel remodeling 6–9. Elastic 




complications, including acute myocardial infarction (MI) and the need for 
emergency CABG 7. Balloon inflation induced endothelium denudation and intimal 
and medial dissection result in the lack of prostacyclin (PGI2) and nitric oxide (NO) 
sources that inhibit smooth muscle cells (SMC) proliferation and migration. In 
addition, exposing blood to the sub-endothelial matrix leads to platelete activation 
and aggregaton which not only promote thrombosis, but also release growth 
factors to further promote SMC to enter the cell cycle 10,11. This neointimal 
hyperplasia again contributes to acute vessel closure and now referred as post-
angioplasty restenosis. 
To overcome these complications, bare metal stents (BMS) were created. 
They are mesh tubes crimped onto balloons, inserted with catheters and left 
behind to scaffold the balloon-dilated artery. The first stent implanted in a human 
coronary artery was performed in 1986 by Dr. Sigwart with a stainless steel self-
expandable stent 12. The first balloon expandable stent, the Palmaz-Schatz® 
(Johnson & Johnson, New Brunswick, NJ), was implanted in 1987 13. These 
devices, indeed, prevented elastic recoil, sealed dissections, and demonstrated 
superiority over POBA in multiple clinical studies by providing permanent radial 
support to the arterial wall 13–16. However, they are overcome by a high incidence 
of in-stent restenosis (ISR) which proliferation and migration of SMC within the 
stents re-obstructs the vessel 17. This is again due to the loss of endothelial cell 
integrity caused by stent implantation and thereafter loss in expression of critical 




of neointimal generated following stent implantation was sometimes even larger 
than the one following POBA 16. Several risk factors, such as long lesion length, 
overlapped stents, small vessel caliber, strut thickness, and strut surface 
topography have been identified as the major contributors to high rate of ISR 18–20.  
Drug eluting stents (DES) was designed to release anti-proliferative drugs 
to specifically address the problems of ISR. These drugs were incorporated within 
a polymer, coated on the surface of stent struts, and were slowly released over a 
few weeks after implantation. They can either attack the mammalian target of 
rapamycin (mTOR) to arrest SMC at the late G1 to S phase of the cell cycle 
(Sirolimus) 21 or interfere with the microtubule polymerization to stop cell replication 
at G2/M phase (Paclitaxel) 22, and consequently suppress SMC proliferation and 
migration. The use of the first generation DES, including Cypher® (Cordis), a 
stainless steel stent coated with a mix of sirolimus, polyethylene-co-vinyl acetate 
(PEVA), and poly n-butyl methacrylate (PBMA), and TAXUS® (Boston Scientific), 
a stainless steel stent coated with a mix of paclitaxel and poly(styreneb-
isobutylene-b-styrene) (SIBS), dramatically reduced the rate of ISR 23,24. However, 
stent thrombosis (ST), especially very late stent thrombosis (VLST, >1 year after 
implantation), emerged as an even greater concern. Though it is a rare event, ST 
is associated with a significant mortality which 10% to 30% of patients with definite 
ST will die 25,26. Multidimensional events, such as indiscriminate drug effects on 
already injured surrounding endothelial cells, durable polymer coatings after drug 




thick struts, and/or persistent or acquired malapposition of the stent strut interfere 
profoundly with the healing process, leaving the artery exposed at increased risk 
of inflammation and ST 27,28. DES thus relegate patients to lifelong need for vigilant 
adherence to dual antiplatelet therapy (DAPT), the use of two powerful drugs to 
block platelet function 27, which itself may lead to excessive bleeding 29. 
There have been major refinements in the material, design, drug, and 
polymer over the last few years to pursue better DES. Cobalt-chromium (CoCr) 
and platinum-chromium (PtCr) have replaced stainless steel as the new materials 
in stent platform. They allow stents to have significantly thinner struts to minimize 
hemodynamic disruptions without compromising radial strength or corrosion 
resistance 30. New anti-proliferative drugs, such as zotarolimus and everolimus, 
have sometimes shown superiority in efficacy and safety in clinical practices 31–34. 
Directional drug delivery, which drugs are only coated on the abluminal side of the 
stent, is used to reduce the amount of drugs and polymers to be loaded and 
enhance endothelization or reduce platelet adhesion 35. DES coated with 
biodegradable polymers such as poly(lactic-co-glycolic acid) (PLGA) 36, or 
polymer-free DES which incorporating drugs into a microporous surface 37, are 
also created to reduce the risk of inflammation associated with durable polymer 
coatings. However, the permanent presence of the stent platform still raises 
concerns that they will forever impede full vascular repair, leaving the artery 
exposed to chronic reactivity, vessel caging, limited re-intervention, alteration of 




limitations are why the community looked to bioresorbable scaffolds for relief. 
 
1.2. Bioresorbable Scaffolds 
Bioresorbable scaffolds (BRS) have the potential to address many of the 
late complications associated with the use of permanent metal stents. Their use is 
based on the presupposition that radial support is only required temporarily 
because neointimal formation and lumen area reduction tend to stabilize 
approximately three months after intervention in the absence of any scaffolding 41. 
Therefore, the existence of a metal foreign body after vessel remodeling will be 
redundant and problematic.  
The conceptual life cycle of BRS can be divided into three phases based on 
its functionality and the physiological responses of the implanted vessel 42 (Figure 
1). During the first three to six months, biological reactions are highly active due to 
the damages to the endothelial cells caused by scaffold implantation. BRS should, 
like all metal stents, provide sufficient lumen support to prevent vessel recoil, seal 
intimal dissection, and release anti-proliferative drugs at a controlled rate to inhibit 
neointimal formation. Minimal mass loss should be found and the radial strength 
should be maintained at the highest level. Molecular weight decreases uniformly 
but macroscopic functions should not be affected. As re-endothelization starts to 




discontinuous. This releases the vessel from scaffolding and allows it to recover to 
a normal vasomotor tone. After the return of vascular functions, the device should 
no longer perform any active functions. Mass loss starts to increase dramatically 
as the degraded elements start to diffuse into the surrounding tissue or the 
bloodstream. The degraded elements should not cause any toxic effects during 
resorption. Absence of a foreign material may reduce the requirements for 
prolonged DAPT, resulting in the potential reduction in associated bleeding 
complications. It leaves no triggers for thrombosis, such as altered local 
hemodynamics, lack of re-endothelialization, and impaired endothelium functions. 
In addition, it allows restoration of vasomotor tone, adaptive shear stress, late 
luminal enlargement, late expansive remodeling, future interventions at the same 
site, and non-invasive imaging such as computed tomography (CT), and releases 
side-branches from vessel caging. 
 
   
Figure 1: Classic paradigm of bioresorbable scaffolds resorption. Molecular weight 
follows a homogenous decline. Mechanical support is maintained for significant 
time until active biological reactions have ended and tissues have recovered from 





Poly-l-lactic acid (pLLA) is by far the most commonly used material for    
BRS 37. Other materials including erodible metals, such as magnesium alloy, and 
copolymers, such as tyrosine-derived polycarbonate and poly-l-lactide-co-ε-
caprolactone, are also being investigated (Table 1). Currently, a few BRS have 
received the Conformité Européenne (CE) mark, and only one, the Absorb 
Bioresorbable Vascular Scaffold (BVS, Abbott Vascular, Santa Clara, CA), was 
approved by U.S. Food and Drug Administration (FDA). BVS consists of a pLLA 
scaffold, a layer of poly-(D, L-lactide) (pDLLA) mixed with an anti-proliferative drug, 
everolimus. It has a thickness of 157 µm and is designed to support the vessel for 
at least 6 months and then fully degraded within 3 years. 
However, BVS failed to show non-inferiority in comparison to a commonly 
employed DES, the Xience evelimous-eluting CoCr stent (Abbott Vacular, Santa 
Clara, CA), in clinical trials. A device-oriented composite endpoint which includes 
cardiac death, target vessel myocardial infraction (TV-MI), and target lesion 
reascularization (TLR), was signicantly higher in the BVS group than in the DES 
group at all times (acute: 0 – 24 hr, subacute: 24 hr – 30 days, late: 30 days – 1 
year, and very late: >1 year after implantation). The difference between devices 
was mainly driven by TV-MI, including peri-procedural MI (Figure 2) 43. In addition, 
patients undergoing PCI with a BVS had increased definite/probable scaffold 
thrombosis at all times compared with DES 43. Concerns regarding increased rate 
of scaffold thrombosis was first raised by the GHOST-EU (Gauging coronary 




Medical Center) registries 44,45. They reported an alarmingly high incidence of 
scaffold thrombosis up to 2.1% at 6 months, and 3.0% at 1 year of follow up, 
respectively, while real-world rate of ST in DES is often below 1% 29. These 
findings were later confirmed with other clinical trials at post-implantation, 1 month, 
6 months, 1 year, 2 years and 3 years of follow up, showing scaffold thrombosis 
was mostly clustered at acute, subacute and very late timeframes 43,46–48. In 
addition, at a 3 year of follow up, the use of BVS did not show any superiority with 
respect to DES in angiographic vasomotor reactivity after administration of 
intracoronary nitrate 43. It also failed to show non-inferiority in angiographic late 
lunminal loss 43. In the light of the early and late safety issues assocaited with BVS, 
and lack of expected long-term benefits, plus the fact that patients and lesion types 
in these BVS studies would be less complex than those in the DES studies, FDA 
released a safety warning of increased risk of major adverse cardiac events with 
BVS in 2017. Shortly after, all BVS were pulled away from the market. 
Potential causes underlying high rate of clinical failures after BVS 
implantation were reported based on case reports with intracoronary imaging, such 
as intravascular ultrasound (IVUS) and optical coherence tomogrphy (OCT) 49.  At 
acute and subacute timeframes, strut malaposition, incomplete lesion coverage, 
scaffold underdepolyment, and acute disruption ranging from local overhanging 
single struts to complete pattern disruption were identified. At late and very late 
timeframes, strut malaposition, uncovered struts and late discontinuity, and late 




flow, alter endothelial shear stress, and thus initiate clinical complications, such as 
scaffold thrombosis. 
Strut thickness of the first generation BRS is often blamed as one of the 
major factors that contributes to uncovered struts, hemodynamic disruption, and 
scaffold thrombosis. The inherent weakness in stiffness and strength of the pLLA-
based BRS requires struts that are much thicker than metal stents to provide 
sufficient radial support 50. Thickness breeds flow disruption and produces 
recirculation zones that trap molecules such as red blood cells, platelets, and 
fibrinogen, prolong their reaction time, and set off the very cascade of effects the 
Figure 2: Clinical outcomes of BVS and Xience. The use of BVS doubled the 
rate of DOCE. Higher rate in the acute time setting is associated with thicker 
struts, sub-optimized implantation procedures, early loss of structural integrity 





devices are intended to countermand 51,52. Next generation devices currently under 
development are trying to reduce the thickness. Meanwhile, prolonged DAPT is 
reemphasized after BRS implantation to prevent late and very late scaffold 
thrombosis, yet interruption of DAPT was only associated with 22% of scaffold 
thrombosis cases 46. In addition, the risk of periprocedural MI was still increased 
with BVS compared with first generation DES which have similar strut thickness 53, 
indicating thickness is not the only contributor. 
Lack of proper operation techniques, such as device-vessel mismatch, 
insufficicent lesion preparation, inadequate post-dilatation, underexpansion, and 
overlapping struts, was considered as another major factor underlying inferior 
clinical outcomes. It causes acute malaposition, underdepolyment, and incomplete 
lesion coverage. Corrective strategies focus on optimzing implantation with 
predilation, scaffold sizing, and postdilation (PSP), where noncompliant balloons 
are used before implantation to prepare the lesion, and again after implantation to 
reduce malaposition. Intracoronary imaging tools are used to guide scaffold sizing. 
These procedures could potentially reduce clinical failures at 1-year follow-up 54. 
However, loss of scaffold integrity and acquired malaposition due to strut 
disruptions during acute and subacute timeframes 49, and increasing inferior 
performances with respect to metal stents at all times 43, point to issues related to 
dynamic changes in scaffold materials and design features rather than tecnique 




largely inherited from its metallic counterparts which has been ignoring the intrisic 
dynamic properties of polymers. This not only misleads researchers to examine 
wrong criteria at wrong spatial and time scale, but also limits the understanding of 
predictable quantifications of the occurrence of clinical failures. Relying on clinical 
work to reveal defects embedded in these devices is fundamentally flawed and the 
outcome is simply catastropic. The failure of the 1st generation BRS raises the 
need of a new research paradigm specifically designed for BRS to better assess 
the performances of these devices. 
 
1.3. Objectives and Outline of Chapters 
The fundamental differences in the material properties of bioresorbable 
polymers and metals force use of different research strategies to anticipate failure 
modes which are unique to BRS and rule out hidden design defects during early 
developmental phases. The aim of this dissertation is to identify potential failure 
modes associated with the 1st generation BRS via a research frame specifically 
designed for BRS. In addition, the introduction of this novel integrated frame may 
aid the design and development of future generation BRS, and all devices using 
bioresorbable materials. 
In summary, failures of the 1st generation BRS are potentially originated 




fabrication techniques inherited from making metal stents. These failures start to 
emerge during device crimping and inflation due to microstructural disruption 
caused by large deformations, and could be easily ignored using evaluation criteria 
from metal stents. They are then enlarged after implantation under the influences 
of cyclic multi-modal asymmetric loadings, and develop into two major 
macroscopic failure modes, including fracture-induced loss of structural integrity at 
acute and subacute timeframes, and/or asymmetric degradation-induced localized 
deformation at late and very late timeframes. These different macroscopic failure 
modes are often ignored in current BRS evaluation processes, which may lead to 
unpredictable hemodynamic disruption and thus clinical complications. 
In the following chapters, we describe in detail our research strategies in 
evaluating the 1st generation BRS, reveal potential failure modes of BRS that may 
lead to inferior clinical performances, and provide insights into the optimization in 
designing, characterizing, and operating next generation BRS. We redefine three 
major components required in evaluating BRS including quantification of: 1) 
materials’ mechanical properties to understand periprocedural device behaviors; 
2) device durability to assess acute and sub-acute performances; and 3) material 
microstructures to understand device degradation and predict long term 
performances. First, we describe a comprehensive mechanical characterization 
performed on pLLA specimens, and a finite element (FE) model developed to study 
the stress distribution within scaffolds during crimping and inflation to advice on 




development of a novel, high-throughput, multimodal fatigue apparatus, validated 
by animal and FE models, to study scaffold durability under a physiological 
relevant loading condition (Chapter 3). Next, we focus on device degradation by 
utilizing Raman spectroscopy to study microstructural heterogeneities and reveal 
the existence of asymmetric spatial degradation and localized deformation 
(Chapter 4). Finally, we provide overall conclusions and close with perspective and 































































































































































































































































































































































































































































































































































































































































































































CHAPTER TWO: EFFECT OF WORKING ENVIRONMENT AND TECHNIQUES 
ON BIORESORBABLE SCAFFOLD PERFORMANCES 
2.1. Introduction 
Poly-l-lactic acid (pLLA) is the most commonly used material for BRS due 
to its fairly abundant supply, high strength and modulus, and, more importantly, 
non-toxic degradation by-products through simple mechanisms such as hydrolysis 
55. However, pLLA is fundamentally different from metals, in terms of its dynamic 
properties, material behavior, and heterogeneous microstructures 56. These 
unique structural features require distinct research paradigms that cannot be 
assumed to mimic metal devices. Ignoring such differences and simply inheriting 
evaluation strategies from other durable materials might well bring catastrophic 
clinical outcomes, and may be why mounting clinical evidences show increased 
rate of thrombosis and myocardial infarctions with BRS 57,58.  
Coronary stents undergo a 2- to 3-fold radial reduction at crimping and 
equal or more expansion at inflation, and are exposed to cyclic asymmetric strain 
from each heartbeat. Rigorous benchtop experiments, from material level tests 
such as stress-strain analysis using dog-bone specimens, to durability analysis on 
simplified geometries, and to device level tests such as crush resistance test, radial 
expansion/compression test, and longitudinal tensile/compression test, are thus 
enforced to provide thorough mechanical characterizations on these devices 59–61. 




on finite element (FE) analysis drawing on mechanical responses characterized 
from benchtop stress-strain tests 62,63. Radial strength, stress distribution, recoil 
percentage, dog-boning effect, and stent-artery interactions have been reported 
using both implicit and explicit strategies 63–65. Yet, the accuracy of FE analysis 
highly depends on benchtop mechanical characterization. 
Unlike metals which possess relatively stable mechanical properties under 
physiological conditions, mechanical responses of polymer materials vary largely 
due to their high sensitivity in testing environment. We hereby emphasize that 
material behavior would critically change depending on the working environment. 
The fact that BRS are designed and tested in dry condition, and then implanted in 
continuous contact to blood flow may cast serious doubt on the accuracy of 
preliminary design steps when material characterization might not comply with 
realistic material behavior in situ. Differences in yield strain, stiffness, strain at 
break and ultimate tensile strength have been found when tested in air and in 
submerged conditions 59 while majority of studies relied on one condition ignoring 
the implications of the other in terms of more comprehensive material 
characterization. Furthermore, limited studies have appreciated this critical 
concept, specifically while modeling the device performance and treatment 
efficacy. As the crimping procedure is done in air while the inflation is performed 
when BRS is inserted into the artery and in contact with blood, the design analysis 
and structural modeling should accordingly consider material properties tested 




In addition to distinguishing the environment the device is exposed to, the 
rate of operation may also alter its mechanical properties due to viscosity 63. There 
has been a strict implantation instruction devised by BRS manufacturers for 
physicians to follow in terms of designated deployment rate, substantially slower 
compared to metal stents, to prevent acute fractures or reduce recoil after 
implantation 54. Yet, no explicit limit has been set to specify the optimal rate. One 
important circumstance that has also been ignored thus far is the fact that crimping, 
as well, creates microstructural deformations which can develop into more severe 
structural failures in future 56. Proper investigation of crimping and inflation rate is 
required to potentially minimize microstructural failures and ensure optimal 
practice in clinics.  
We conducted uniaxial tensile tests on dog-bone samples obtained through 
laser cutting clinical-grade pLLA tubes. Tests were performed in both air and 
submerged conditions at different velocities. FE analysis was then performed with 
material properties derived from both conditions to help compare stress distribution 
and recoil percentage (%recoil) to verify the efficacy of device. In addition, we 
compared two different designs in terms of stress concentration. This extensive 
approach of material characterization and device performance assessment may 
shed further light on the mechanistic knowledge of how the BRS would behave at 
their early stages of service in physiological settings to not only delineate a portion 
of clinical events observed for BRS but also provide design teams with insights to 




2.2. Materials and Methods 
2.2.1 Material Preparation 
pLLA dog-bone specimens and fully resorbable pLLA scaffold systems 
provided by the Boston Scientific Corporation were used in all experimental 
conditions unless otherwise specified. Scaffolds are 16 mm in length, 3.0 mm in 
inner diameter before crimping, and have a wall thickness of 105 µm. Two designs, 
one with a slot feature at its inner peak edges, namely slot design, and the other 
without the slot feature, namely non-slot design, were investigated (Figure 3). Dog-
bone specimens were obtained through laser-cutting using the same extruded 
tubes used to generate scaffolds (Figure 4). All specimens were carefully extracted 
having the loading axis aligned with the longitudinal axis of the extruded pLLA tube. 
Scaffolds and dog-bone specimens were stored at 4 oC prior to experiments. 
 
Figure 3: BRS macro- and micro- scale system.  A) Microscopic view of a scaffold. 
B) Fully resorbable scaffold systems. C) Scanning electron micrograph of strut 




2.2.2 Uniaxial Tensile Test on pLLA Dog Bone Specimens 
Mechanical properties of the material were predominantly characterized by 
the uniaxial tensile test. The hardening curve resulted from the experiment 
described evolution of the yield stress during the deformation. In a real-world 
working environment, scaffolds are in direct contact with blood once being inserted 
into a patient’s artery. It normally takes clinicians a few minutes to reach the target 
lesion site and inflate the balloon. Thus, to better mimic the real clinical practices, 
the experimental setup (Figure 4B, Bangalore Integrated System Solutions, India) 
included a water chamber to allow the specimens stretching after 10 minutes of 
immersion. A dog-bone specimen was mounted onto two clamps, and immersed 
in water at room temperature and then stretched by the presented testing machine. 
The axial load cell signals were recorded in real time and compiled by a computer-
based data acquisition system. Experiments were accomplished in the range of 
quasi-static to dynamic stretching condition with three constant cross-head 
velocities, 0.001, 0.01, and 0.1 mm/sec, defined as slow, moderate and fast, 
correspondingly, until fracture. It is safe to assume 0.001 mm/sec as a quasi-static 
condition. Three specimens were tested in each of the fast and moderate scenarios. 
One specimen was tested in slow scenarios as minimum variations were seen at 








Figure 4: Experimental setup for uniaxial test on dog-bone specimens. A) Dog-
bone dimensions in mm. B) Biaxial tensile tester with 1) water chamber, 2) dog-
bone specimens; 3) clamps; 4) LED lightening; and 5) load cell. 
 
Deformations were observed and recorded by the Digital Image Correlation 
(DIC) method. This non-contact and material-independent optical measuring 
system is extensively being used to monitor the displacement history and strain 
distribution in mechanical applications. All experiments were monitored with a 
high-resolution digital camera. Front surfaces of all specimens were speckle-
painted using an airbrush leaving behind randomly patterned black points. The 
resulted images including the entire experiment up to fracture were then imported 
to the DIC software, VIC-2D (Correlated Solutions), to quantify the displacement 
field and the planar surface strains. Effective strain distribution of uniaxial tensile 
samples subjected to different stretching velocities before fracture were assessed 






Figure 5: Effective strain distribution of uniaxial tensile samples for dry and wet 
conditions subjected to different stretching velocities. Scale bars indicate strain. 
 
 
2.2.3 Material Parameter Calibration 
Material parameters for the numerical analysis were extracted from the true 
stress – true strain experimental curves. The Young’s modulus was calculated 
based on the elastic region of the experiment. Abaqus/Standard 2017 (Dassault 
Systèmes, Providence, RI) was used as finite element software. Johnson-Cook 
plasticity model was employed to capture the non-linear material hardening 
behavior after yielding and the strong dependency on testing velocities. The 
temperature dependence of the model was deactivated as the tests were 




setting. The yield stress 𝜎 is reported hereinafter: 
𝜎 = [ 𝐶1 + 𝐶2(𝜀̅
𝑝𝑙)𝑛][1 + 𝐶3 ln(𝜀̅̇
𝑝𝑙 𝜀̅̇0⁄ )] 
where 𝜀̅𝑝𝑙  is the equivalent plastic strain, 𝐶1 ,  𝐶2 , 𝐶3 , n and 𝜀̅̇
0  are material 
parameters of the model and 𝜀̅̇𝑝𝑙 is the equivalent plastic strain rate. 𝐶1 is the yield 
stress in static conditions, which is assumed to be the value at the slow case. 𝐶2 
and n regulate the shape of the static curve in terms of slope and concavity.  𝐶3 is 
the scaling parameter between the static material curve and the response at 
different strain rates. The parameters for both dry and submerged scenarios were 
identified by enforcing the exact match of the analytically calculated curves over 
the experimental ones obtained at three different velocities. 
 
2.2.4 Verification of Material Properties 
A dog-bone-shaped 3D model was implemented in Abaqus/Standard to 
numerically replicate the experimental tensile tests, wherein all dimensions and 
parameters accurately traced the experimental settings. A dynamic/implicit solver 
was used to simulate all six scenarios with parameters identified above. 
Displacements in all directions were constrained (U1 = U2 = U3 = 0) on one end of 
the specimen while a uniaxial displacement (U1 ≠ 0) was applied in a fixed time 
span (ΔT) on the other, duplicating the experiment. The model was discretized by 




analysis on the refinement was conducted up to an element size of about 0.05 mm. 
The applied displacement and the reaction force were extracted and compared in 
a force-displacement plot to the experimental counterparts (Table II) 
Table II: Displacements (U1) and durations (ΔT) applied in finite element set-ups 
to replicate experiments 

















2.2.5 3D Validation of the Scaffold Geometry 
A longitudinal tensile and a lateral crush resistance test were conducted on 
nonslot design scaffolds to validate the robustness of both the material and 
geometrical numerical descriptions. In the longitudinal tensile test, scaffolds were 
fixed onto a tensile tester (Figure 6A) and stretched at a constant velocity of 0.1 
mm/sec for 70 seconds. In the lateral crush resistance test, scaffolds were placed 
in the middle of two flat plates (Figure 6C) and compressed at a constant velocity 
of 0.1 mm/s up to a displacement of 2 mm. These conventional tests were chosen 
due to their simplicity and similarity to in-vivo loads experienced by BRS. 
A 3D finite element model of the scaffold was constructed in Abaqus/Implicit 




incompatible mode element (C3D8I) was created by Hypermesh (Altair 
Hyperworks). Incompatible modes elements were chosen based on their accepted 
performances in describing bending-dominated problems such as the one 
occurring in scaffold deformation during crimping and inflation. The total number 
of elements is 242785, with four elements designated across the strut thickness. 
The numerical models were implemented in a dynamic/Implicit simulation, 
replicating the geometries, applied boundary conditions, and duration of the 
experiments. Material properties derived from submerged conditions were used in 
this analysis since experiments were conducted in water. The elastic modulus was 
set to 1.4 GPa. In the longitudinal tensile test (Figure 6B), both ends of the scaffold 
were linked to two multipoint constraints. One end was fixed (U1 = U2 = U3 = UR1 
= UR2 = UR3 = 0) while the other was under axial tension (U3 = 7 mm). The total 
step time was 74 secs in chorus to the experiment. In the lateral crush resistance 
test (Figure 6D), an unconstrained scaffold was positioned between two identical 
planar rigid surfaces (quadrilateral surface element with reduced integration, 
SFM3D4R, 341 elements). The bottom surface was fixed (U1 = U2 = U3 = UR1 = 
UR2 = UR3 = 0) while the top surface vertically moved (U2 = 2 mm), impacting the 
lateral surface of the scaffold with compression forces. The contact was defined 
as “hard contact” with a friction coefficient of 0.2 between the surfaces and the 
scaffold. The total step time was 20 secs according to the experiment. In both 
cases, the applied displacement and the reaction force were extracted and 





Figure 6: Experimental and computational setups for material model validation. A) 
Longitudinal tensile test on a full-scale device, B) The corresponding finite element 
model of full-scale device before (top) and after (bottom) the test, C) Lateral crush 
resistance test, D) Side view of the corresponding finite element model of full-scale 
device before (left) and after (right) the test. 
 
2.2.6 FE Analysis on Scaffold Crimping and Inflation 
Employing Abaqus/Explicit, crimping and inflation were solved incorporating 
two sets of material properties, dry and submerged, for two different designs. The 
simulation set-up strived to mimic a real clinical intervention scenario. The time-
scaling factor has been set to 1 with a target time increment of 1×10-4. Interaction 
between all the surfaces was defined as “general contact” with a friction coefficient 
of 0.2. The framework of the simulation and its steps could be described as follow: 
1. Crimping: An unconstrained scaffold (density = 1.4 g/cm3) was radially 
compressed by an external rigid cylindrical surface (initial diameter = 3.2 
mm, SFM3D4R, 3’952 elements). 1 mm radial displacement was applied. 




3. Intraluminal positioning: The crimped scaffold was positioned inside a mock 
vessel (density = 1.16 g/cm3, E = 1.46 MPa, Poisson’s ratio = 0.3, internal 
lumen diameter = 3.0 mm, thickness = 0.5 mm, 100’500 elements, C3D8I). 
4. Inflation: An internal cylinder (initial diameter = 1.0 mm, 1’400 elements, 
SFM3D4R) radially expanded the scaffold to an inner diameter of 3.4 mm 
(about 12% of overexpansion to guarantee good apposition). 
5. Relaxation: The internal cylinder was maintained at the expanded state with 
the step time of 30 secs to allow stress relaxation in the scaffold. 
6. Recoil: The internal cylinder was reduced to 0.1 mm to allow free recoil.  
Three different step times were considered for crimping and inflation to 
evaluate the effect of operational rate on the scaffold performance (Table III). 
Table III: Step duration for step 1 and 4 in each finite element simulation 
 Fast Middle Slow 
Step 1: Crimping 6 secs  60 secs  600 secs 
Step 4: Inflation 10 secs 20 secs 40 secs 
 
Values of the von Mises equivalent were extracted at the end of the crimping 
and inflation phases to assess the effect of operational rate on stress concentration. 
Recoiling percentage (%Recoil) was calculated for all scenarios: 
%𝑅𝑒𝑐𝑜𝑖𝑙 = (𝐷1 − 𝐷2) 𝐷1⁄  
where D1 and D2 are the outer diameter of the scaffold at the end inflation and 





2.3.1. Mechanical Response of pLLA 
True stress – true strain curves were plotted to compare dry and submerged 
samples at three different testing velocities including 0.1 mm/s, 0.01 mm/s and 
0.001 mm/s (Figure 7). Similar visco-plastic behavior was observed for all loading 
conditions, i.e. after passing the yield point, a small amount of stress softening was 
followed by stress hardening till the sample fractured. The minimum stress 
evolution was recorded under the quasi-static condition in both dry and submerged 
conditions. In dry condition (solid lines), lower velocity leads to lower elastic 
modulus (E), higher yield strain (𝜀?̅?), lower yield stress (𝜎𝑦),  higher fracture strain 
(𝜀?̅?), and higher fracture stress (𝜎𝑓) (Table IV). In submerged condition (dash lines), 
the effect of testing velocity on mechanical responses are not as clear as in dry 
cases. Although 𝜀?̅?, 𝜎𝑦, and 𝜎𝑓 in submerged condition have similar trends as in 
dry condition, the fast and moderate samples show comparable elasticity, which 
reduces when experiment velocity is the slowest. At a comparable velocity, a clear 
difference can be seen between dry and submerged conditions, wherein reducing 
the testing velocity diminishes the observed disparities. This observation 
emphasizes the necessity to apply proper mechanical properties during FE 
analysis. In general, submerged samples exhibit less resistance to yielding, higher 
deformability, and softer behavior compared to dry cases. Based on statistical 




moderate scenarios (p = 0.017 and 0.031 in fast and moderate scenarios, 
respectively). In addition, yield stress is also significantly lower in submerged 
condition in moderate scenarios (p = 0.028). 
 
Figure 7: True stress – true strain curves of pLLA tested in dry and submerged 




2.3.2. Verification by the FE Model 
True stress – true strain curves generated from FE analysis mimicking a 
uniaxial tensile test on dog-bone specimens were highly correlated to results 
obtained from benchtop tests in both dry and submerged conditions (Table V, 
Figure 8A&B). In addition, experimental force – displacement curves for full-scale 
scaffold tests, including the longitudinal tensile test and the lateral crush resistance 




Table IV: Key mechanical properties from uniaxial tensile test 
 Dry Submerged 
Testing Velocity 
(mm/sec) 
















































Table V: Simulation coefficients 













n ε0̇ (1/s) 
Dry 1.5 1.1 0.9 62 223 0.12 1.39 0.0002 






Figure 8: Model verification using finite element analysis. Stress–strain curves of 
dog-bone samples tested at various velocities in (A) dry and (B) submerged 
conditions. Results of C) longitudinal tensile and D) lateral crush resistance test on 
a full-scale device. Fast: 0.1 mm/s, Moderate: 0.01 mm/s, and Slow: 0.001 mm/s. 
 
2.3.3. Design Effects on Scaffold Performance 
Stresses concentration was highly correlated to specific design features 




deformations were clearly visible in experiments and predicted by the numerical 
simulation at inner peak edges (Figure 9A). However, device inflation promoted 
dimple deformations at outer peak edges (Figure 9B), wherein development of 
inner sides’ deformations into micro-cracks were observed (Figure 9C). These 
alterations in structural integrity prior and during scaffold implantation may 
potentially develop into catastrophic structural failures after implantation (see 
Chapter 3) in situ and may, in part, explain events observed in clinical trials. 
 
 
Figure 9: Consistency of finite element outputs on von Mises stress concentrated 
areas and localized damages in microscopic images of A) crimped and B) inflated 
device in a submerged condition at moderate velocity. During crimping, stress 
concentrated at inner peak edges causes localized deformations. After inflation, 
deformations observed at outer peak edges. C) Micro-fractures were found at inner 
peak edges of a submerged scaffold after inflation at the moderate velocity (shown 
by arrows). 
 
Adding slots at peak features of the scaffold effectively reduced high 
stressed areas during crimping and inflation. During crimping, maximum stress 
occurred at inner peak edges in both designs, and it was more than doubled in 
non-slot designs (337 MPa) compared to slot designs (159 MPa) (Figure 10A). 




inflation, maximum stress was also found at inner peak edges (Figure 10B). It was 
similar in both non-slot (493 MPa) and slot designs (524 MPa), but more elements 
were experiencing extreme stresses in non-slot designs (4.4% of elements 
experiencing stress over 200 MPa) compared to slot designs (2.4% of elements 




Figure 10: FE analysis on von Mises stress distribution during A) Crimping and B) 
Inflation of BRS. Maximum von Mises stress was found at inner peak edges during 
crimping and inflation. Non-slot designs have more high stressed elements 
compared to slot designs.  
 
 
2.3.4. Procedural Effects on Scaffold Performance 
As a representative measure of regions with the risk of failure, the 






and 150 MPa were quantified after scaffold were crimped and inflated at different 
rates and working environments (Figure 11). Yield stress represents the start of 
plastic deformation and indicates permanent microstructural damages. Yield 
stress for dry specimens at fast, moderate and slow rates are 70 MPa, 65 MPa, 
and 62 MPa, respectively, while they were slightly lower in submerged specimens 
(63 MPa, 60 MPa, and 59 MPa, respectively at fast, moderate and slow rates) 
(Figure 7). The value of 150 MPa was chosen because it was about the value of 
the ultimate tensile stress indicating fracture, while 100 MPa was an intermediate 
stress intentionally selected between yielding and fracture phases to represent the 
credibility of FE simulation to capture stress distribution consistency. More than 
half of elements experienced stresses higher than their yield criteria when 
scaffolds were crimped in dry condition at fast, moderate, and slow rates (69%, 
61% and 59% of elements, respectively) (Figure 11A). While in submerged 
samples, lower percentage of elements yield at similar crimping rates, i.e. 60%, 
59%, and 49% when crimped at fast, moderate, and slow rate, respectively (Figure 
11B). Inflation of the device exerts critical stresses to higher number of device 
elements in both dry and submerged conditions (Figure 11C&D). Comparing the 
submerged and dry samples, reducing the operational rate considerably drops 
percentage of elements experiencing the yield in the latter. In general, low, yet 
concerning proportion of elements experience stresses beyond the fracture point, 
with higher values for dry samples. In addition, in both working 




with what has been reported in clinics for this viscoelastic-plastic device. Overall, 
the percentage of elements experiencing extreme levels of stresses decreases as 
the operation slows down regardless of the environment the specimen is exposed 
to. This implies that slow operational rate may reduce stress concentration, and 
thus lower potential damages caused by deformations  
 
Figure 11: Percentage of elements with von Mises stress higher than certain stress 
thresholds for a device experimented at different procedural rates for crimping at 
A) Dry and B) Submerged condition, and inflation at C) Dry and D) Submerged 
condition. The percentage of elements experiencing extreme levels of stresses 
decrease as the procedure slows down regardless of the functioning environment. 
For submerged samples, at the same procedural rate, less number of elements 





Stents experience extreme stresses and large deformations while being 
crimped or inflated, even before they serve scaffolding diseased vessels under 
cyclic asymmetric loadings. These loads may increase the likelihood of mechanical 
failure for BRS even more than their metallic counterparts – not just because the 
latter are stronger but also because the stress-strain response of the two materials 
is fundamentally different. Moreover, unlike metals, polymeric materials are far 
more sensitive to changes in environmental (immersive vs dry, warm vs hot 
contexts etc.). Testes that are standard for metal devices might therefore not be 
appropriate for polymeric constructs. Simply inheriting design paradigms of metal 
stents to develop BRS, in which the environment and operation effects on device 
performances have often been ignored, might lead to incorrect assessment of 
mechanical stressors the device faces. Most studies have relied on employing a 
single set of material properties derived from benchtop experiments, usually 
uniaxial tensile tests, conducted under one testing environment, i.e., in air or in a 
submerged environment, to feed higher-level analyses of device performance, e.g., 
crimping, inflation, and load bearing capability 59,66. However, viscoplastic 
polymers, such as pLLA, consist of heterogeneous microstructural compartments 
including crystal domains, where molecules are differentially aligned and packed, 
and amorphous regions where they are randomly oriented. Macroscopic properties 
of such materials, e.g. mechanical strength, deformability, and yield resistance 




and degree of crystallinity. This dependency may lead to completely different 
mechanical responses when tested in diverse environments, e.g. in a submerged 
condition akin to vessel lumen, with lower yielding resistance, higher deformability, 
and softer behaviors (Figure 7). Observed differences between dry and submerged 
scenarios may be due to the alterations in crystallinity and molecular orientation 
caused by re-crystallization and swelling as materials absorb water molecules 56,67. 
We suspect that water molecules within the polymeric matrix act as a resisting 
buffer damping the deforming forces and alleviating the effect of operational rates. 
The dependency of material properties on the working environment is, thus, 
important considering the varying environment BRS are exposed to. In practice, 
BRS crimping is usually performed, as a step in the manufacturing possess, in air 
at a temperature of 37 oC or higher, to reduce material stiffness and prevent micro-
cracks. Whereas, BRS inflation is routinely performed in clinics within 10 minutes 
after balloon-mounted devices are inserted in a submerged environment at body 
temperature. Such significant disparities in the operational environment mandate 
engineers and designer to conduct device characterization in corresponding 
realistic scenarios, and if ignored, may lead to unreliable regulatory tests and 
eventually unpredictable clinical behaviors. Lack of thorough understanding of 
BRS mechanical behavior might well have contributed to the inability to foresee 
clinical consequences 43,46,51,52. 
Intriguingly, corrective strategies to reduce clinical failures have focused 




understanding dynamics 54. Clinicians have been advised to adhere to a strict 
implantation protocol that includes lesion pre-dilation and controlled inflation of 
these devices at a much slower rate compared to their metallic counterparts to 
prevent acute fracture, and reduce recoil 54. However, not only there is no clear-
cut measure on what the optimal rate should be, but also proper criteria specifically 
designed for BRS to determine optimal rate are still missing. Criteria inherited from 
metal stent guidelines including preventing acute fracture and reducing recoil may 
not be comprehensive enough. The implication of our work is that designers should 
conduct more appropriate tests to achieve a comprehensive understanding of 
specific device performance that takes into account intended use and expected 
environment. 
Due to the differences in mechanical behavior when being characterized in 
different environments (Figure 7), different levels of stress concentration have 
been noticed with FE analysis on crimping and inflation of resorbable devices. 
Crimping the scaffold at a slower rate could reduce the risk of exposing large 
percentage of elements to high stresses (Figure 11). However, that we show a 
higher percent of elements underwent high stresses in dry conditions compared to 
submerged conditions raises the concern that one may underestimate the severity 
of stress concentration during the crimping and miss potential modes of failure if 
crimping simulations is fed by material models derived from characterization in 
submerged condition. Similarly, if an inflation model is supported by a material 




effect of inflation time on reducing stress concentration could be noticeably 
overestimated. Reducing inflation time from 20 to 40 seconds can reduce the 
number of elements at stresses above their yield stress by 13% in dry condition 
(Figure 11C), while it is less than half of this value in submerged condition (Figure 
11D). This indicates that optimizing implantation techniques via inflating at a slow 
rate may not significantly reduce the risk of clinical failures. We might therefore 
reconsider the idea that one model alone can provide comprehensive 
understanding and accurate prediction on the device performances.  
Percentage of recoil and acute macro-structural fractures are the two most 
commonly used criteria when assessing the performance of implanted devices. 
However, noticed in our FE analysis, inflating at slower rate seems to have very 
limited effect on preventing recoil (2% difference in %recoil between fast and slow 
scenarios). Thus, procedural factors might alleviate/exacerbate structural 
responses and consequently alter the performance measures such as recoil due 
to their direct influence on material properties. However, the material behavior 
change, as a result of interventional procedure alteration, is extremely nonlinear. 
Corrective strategies merely focused on procedural parameters without noticing 
their complex effect on material modulation may, thus, be misleading as they rely 
on performance measures inherited from metallic counterparts. In addition, several 
in vitro and in vivo experiments have shown that fractures could be avoided when 
slow inflation is warranted. Yet, the catastrophic clinical events linger in clinical 




As a result, continuing to use %recoil and acute macro-structural fracture as mere 
criteria to assess the device efficacy may no longer be a reliable approach nor an 
accurate prediction tool for future research in BRS evolution.  
Instead, we hypothesize that it might be the microstructural composition of 
such a heterogeneous material, its evolution over the rigorous interventional 
procedure, and acute/long-term exposure to dynamic biological environment within 
the body that may determine the device performance. Heterogeneities in BRS 
material properties could induce microstructural damages at certain design 
features (Figure 9) during manufacturing/clinical routines. These localized 
microstructural damages challenge the structural integrity of the devices at an early 
stage, and as they further experience the complex biological and mechanical 
environment in situ, fatigue-induced crack propagation, and strain-induced 
degradation may potentially develop into catastrophic failures in macro-structures, 
such as malapposition, large recoil, and fracture, leading to reported clinical events 
49,56. To minimize such damages, a change in geometry design seems not only 
reduce stress concentration, but also have the potentials to prevent future 
macroscopic failures by blocking fracture propagation (details will be discussed in 
Chapter 3). 
In short, we have further highlighted the importance of incorporating micro-
structural damages such as localized deformation and micro-cracks as device 
evaluation criteria, wherein updates on procedural strategies (reducing rate for 




the stress concentration in certain spatial locations). However, ignoring the effect 
of environment in which the device operates on material characteristics, and 
consequently on preliminary simulations of design and development, may result in 




CHAPTER THREE: DURABILITY OF BIORESORBABLE SCAFFOLDS UNDER 
PHYSIOLOGICAL LOADING ENVIRONMENT 
3.1. Introduction  
Stents implanted via angioplasty need to go through highly curved vessels, 
be expanded 2 to 3 folds, provide sufficient radial support to open narrowed 
vessels with calcified lesions, and withstand all other loadings from the motion of 
the vessel for tens of millions of cycles without failures. Thus, all stents are 
subjected to rigorous benchtop mechanical tests to ensure device safety and 
efficacy as part of their pre-market approval process required by FDA 68. 
Mechanical tests on BRS directly inherit testing protocols from their metallic 
counterparts which involve assessments on the flexibility, strength and durability. 
There are many existing mechanical test configurations proposed to 
evaluate scaffold integrity. Yet, they are widely variable and often limited in scope 
as there are limited technical standards and regulatory requirements existed 68–70. 
One particular challenge to the field is understanding how patient anatomy and 
clinical outcomes on device failures can be translated to particular benchtop setups, 
and how each test can be utilized to improve in vivo performances.  
Benchtop mechanical tests on BRS consist of three major categories: 1) 
material-level, 2) component-level, and 3) device-level characterization. Monotonic 




investigators can understand what level of strength the device can provide in both 
radial and longitudinal direction, how flexible it is at both crimped and inflated 
states, and when and where, and sometimes why it develops structural failures. 
 
3.1.1 Material Level Mechanical Characterizations 
Uniaxial tensile tests are the standard method of choice for characterizing 
mechanical properties of bulk materials. Samples are usually in the form of dog-
bones, or sometimes wires extracted from the stent body 63,71. Stress-strain 
behaviors can be attained and basic mechanical properties such as material 
stiffness, yield strength, toughness, ultimate tensile strength, plasticity, and 
viscosity, can be quantified. This information is particularly useful in assisting FE 
analysis on geometry selection and periprocedural performance assessments. 
However, the output of this test is limited in providing long-term predictive failure 
data. In addition, the unique sensitivity of BRS to the testing environment should 
be well considered as we discussed in details in Chapter 2.  
Fatigue tests on bulk materials are also investigated. Cyclic bending or 
uniaxial tension are applied to wire- or oar-shaped specimens 72,73. The outcome 
of these tests is often an S/N curve (S: alternating stress value, N: number of cycles 
to failure) providing the value of stress below which a fracture will not happen, and 




provide the statistically predicted number of cycles to failure and are useful in 
understanding the fatigue mechanisms on a microstructural level. However, they 
do not provide any device-level information relevant to in-use fatigue. 
 
3.1.2. Component Level Mechanical Characterizations 
Component level tests are usually fatigue tests performed on a single “unit 
cell” of a scaffold 60. Specimens are often injection molded and/or laser cut into 
diamond shaped patterns mimicking the peak feature of a scaffold. Cyclic uniaxial 
tensions are applied with samples immersed in 37 oC PBS. From the test, the 
relationship between strain amplitude and number of cycles to failure can be 
quantified to provide long-term failure predictions. In addition, the effects of 
mechanical stresses on degradation can be studied by investigating changes in 
material properties, such as molecular weight and crystallinity. This is critical as 
enhanced degradation was found when the polymer was under pre-imposed strain 
74. Though it does take into account the geometry effects to some extent, the use 
of simplified geometries, and more problematically – over-simplified loading 
conditions, in these tests limit the understanding of the true device fatigue-






3.1.3. Device Level Mechanical Characterizations 
Device-level mechanical tests on stents often include radial and longitudinal 
expansion and/or compression, and three-point bending 76–79. Force – 
displacement data are generated to calculate bending stiffness, radial stiffness, 
and strength at fracture/collapse. These methods take into account the complex 
geometry of scaffolds and the physiological deformations. They can assess the 
flexibility, structural integrity, and expansion ability, and determine boundary 
conditions to provide guidance during device deployments.  
Another device-level test is the durability test on scaffolds to examine their 
resistance to structural failures as an intact device when experiencing cyclic 
loadings so that potential geometrical defects can be removed during early 
development phases. Applying a cyclic single mode loading, such as radial 
pulsation 80, axial compression, or bending 81, is the most common way to conduct 
such tests. However, this often fails to identify potential design defects. Animal 
studies conducted at the Boston Scientific Corporation on two scaffold designs 
revealed catastrophic failures in structural integrity in one design at 30 days of 
follow ups while no failures were found for the same design using benchtop tests 
with single mode loading conditions. This indicates the lack of robustness with the 
current device-level durability test. Scaffolds experience multimodal loadings, such 
as axial compression, torsion, and bending, from the motion of the vessel 82–85, 




may lead to non-uniform degradation and deformation. Therefore, it is critical to 
define a benchtop testing environment close to physiological conditions when 
evaluating BRS durability. 
 
3.1.4. Coronary Artery Dynamics 
Designing an appropriate multimodal loading environment requires 
accurate quantification of changes in length, curvature, and twist angle of coronary 
arteries due to cardiac pulsatile motion. Cardiac-gated computed tomography (CT) 
images were used to reconstruct 3D surface geometries of coronary arteries 84,85. 
Centerline paths of the arteries were identified by calculating and connecting the 
centroids of the cross-sectional vessel lumen. For quantification of longitudinal 
strain and twisting deformation, relative translation and rotation of distal landmarks 
with respect to a proximal landmark on the centerline path were computed. For 
quantification of bending deformation, changes in curvature were measured. 
Similar methods were applied onto clinical biplane coronary angiograms in which 
a string of small neighborhood windows was created along the axis of the vessel 
in the two projections to reconstruct 3D images and track the motion of the vessel 
frame by frame 83. Large variations in deformations were found not only between 
the three major coronary arteries, i.e. the left anterior descending (LAD) artery, the 
left circumflex artery (LCX), and the right coronary artery (RCA), but also at 




15o, twist rate is varies from 3 – 5o/cm, and longitudinal compression is about 4 to 
8% 83–85. In addition, artery geometries and dynamics will change after scaffold 
implantation due to the extra degree of straightening, and longitudinal and/or 
torsional stiffness the scaffold provides 82,86,87. Also, patients who need scaffold 
implantation often have underlying atherosclerotic plaques, dissections, and/or 
calcifications that can alter the pre-implantation loading conditions. Thus, it is 
important to take into account the contribution of the scaffold and the vessel/lesion 
features when setting up benchtop loading environments. 
In this chapter, we designed and built a novel, high-throughput, multimodal 
fatigue tester to apply isolated or combined cyclic compression, bending, and 
torsion deformation for assessing the durability of BRS. We conducted fatigue test 
on two different scaffold designs, and successfully reproduced the results from 
animal studies in terms of fracture rate and locations. In addition, we performed 
FE analysis on stress distribution of scaffolds during different combinations of 






3.2. Materials and Methods 
3.2.1. High Throughput Multimodal Fatigue Tester 
A high-throughput multimodal fatigue tester was built to conduct durability 
tests on 12 scaffolds simultaneously (Figure 12). An Allen-Bradley® CompactLogix 
5380 programmable logic controller (PLC, Rockwell Automation, Milwaukee, WI, 
USA) was used to control the system. PLC programming was done using ladder 
logic (Studio5000®, Rockwell Automation, Milwaukee, WI, USA). Twelve individual 
flow loops were arranged in parallel and merged into a heating circulator (Julabo®, 
Allentown, PA, USA) which contains a heated stainless steel reservoir. Twelve flow 
meters were installed to monitor the flow rate in each loop. A high resolution 
camera was mounted on a guide rail over the scaffolds. At pre-defined time points, 
tests were paused and scaffolds were rotated 360o to allow scanning for fractures. 
The system is enclosed in a chamber with temperature control system to maintain 
at 37 oC and minimize environmental disturbance. 
 
Figure 12: High throughput multimodal scaffold tester. A) Panoramic view of the 




Twelve compliant silicone vessels (Dynatek Labs, Galena, MO) with a 
diameter of 2.8 ± 0.2 mm were placed in the center of the system and connected 
to hollow shafts on each end (Figure 13). Scaffolds were inserted into and inflated 
inside the vessels via Y-shape hemostasis valves (Qosina, Ronkonkoma, NY). All 
scaffolds experienced the same type, magnitude and frequency of loadings. Linear 
voice coil actuators (VCA, SMAC, Carlsbad, CA) and servo motors (Kollmorgen, 
Radford, VA) were used to apply cyclic multimodal loadings in a symmetric way, 
consisting of axial compression, bending, and torsion (Figure 13). Axial 
compression was achieved by placing two VCAs on each side of the system and 
connecting to carriages which can move via guide rails. Bending was achieved via 
two VCAs placed underneath and perpendicular to the vessels, and connected to 
two bending rods with a predefined curvature to provide certain bending angles. 
Torsion was achieved with two servo motors connected to a pulley-belt system to 
transmit the rotation to each scaffold. 
 
Figure 13: Cyclic multimodal loadings applied in a symmetric way, consisting of 




3.2.2. Durability Test with Multimodal Loading Environment 
Tests were started with filling all flow loops with PBS. Flow was maintained 
at around 40 – 50 ml/min within each flow loop with temperature stable at 37 oC. 
Scaffolds were removed from the 4 oC fridge and kept at room temperature for at 
least one hour before the test. Scaffolds were inserted into and inflated inside the 
vessels at a rate of 1 atm every two seconds until 
reaching 12 atm. Pressure was maintained at 12 
atm for 30 seconds before deflation. Two 
geometries, the slot and the non-slot design (Figure 
3) were investigated. Three types of loadings, 
including 15o bending (B), 7o torsion (T) and 4% 
axial compression (C), were applied to scaffolds at 
a frequency of 1 Hz for 14 days in seven different 
combinations, i.e. all three combined (B+T+C), any 
two of the three loadings (B+T, T+C, or B+C), or one single loading. Tests were 
paused every 24 hours to scan for fractures. Scaffolds were removed from the 
vessel after the test for fracture analysis. Only full separation of struts was 
considered as fracture. Locations of fractures were sorted in three categories, 
namely, connected peak (Type I), unconnected peak (Type II), and connector 
(Type III) (Figure 14). 
 





3.2.3. Pre-clinical Studies on Scaffold Fractures 
A porcine model served to provide insight into the fracture performance of 
BRS with different designs in an intact living system. Six Yorkshire porcines 
(castrated male or female, weight range 40 – 50 kg) were sedated with an 
intramuscular injection of Telazol at 3.5 – 5.5 mg/kg, endotracheally intubated, and 
maintained under general anesthesia with inhaled isoflurane. 325 mg of Aspirin 
and 150 mg of Clopidogrel were given via oral administration prior to the procedure 
for antiplatelet purposes. Heparin was administering at 20 – 400 IU/kg every 30 – 
45 min during the procedure to elevate the activated clotting time above 250 
seconds. Animals were maintained in accordance with American Preclinical 
Services Standard of Procedure (APS SOP) and monitored by continuous 
recording of oxygen saturation, heart rate, and blood pressure. 
Access to the targeted arteries was achieved via a femoral artery cut down. 
Guided catheters were inserted and directed to the implant sites, quantitative 
coronary arteriography (QCA) were performed to select appropriately sized 
locations. Up to 3 scaffolds, one scaffold in each coronary artery (RCA, LCX, and 
LAD), were implanted in each animal. The target vessel size is 2.50 – 3.50 mm 
diameter. Optimal implantation targeted a scaffold inner diameter to artery ratio of 
1.1 – 1.15 : 1.0, using the mean vessel segment diameter as determined by QCA. 
OCT was used to determine proper stent apposition after initial stent deployment. 




Overall length of the study was 30 days. Prior to termination, QCA was 
performed to measure vessel diameters. OCT was performed to examine the 
existence of overlapped struts, struts protruding or appearing isolated in the lumen. 
Euthanasia was performed per APS SOP. Stent fracture analysis was then 
performed via dissection microscope and Visicon imaging after scaffolded vessel 
excision from the heart. 
3.2.4. FE Analysis on Stress Distribution Under Multimodal Loadings 
FE analysis (Abaqus; Dassault Systèmes, Providence, RI) was performed 
to determine high stressed locations in the scaffold under multimodal loadings. 
Two geometries (slot and non-slot) were investigated. The material model was a 
Johnson–Cook plasticity model with a linear elasticity. The framework of the 
simulation and its steps were the same as described in Chapter 2.2.6. One extra 
step was added at the end of the previous framework with a target time increment 
of 1×10-5 instead of 1×10-4 since lower value is needed to reduce the high inertial 
effects due to high deformation in a short time period. Multimodal loadings were 
applied to the tube mimicking the experimental benchtop. The axial compression 
and torsions were applied at the multipoint constraints. The bending action was 
simulated through the lateral impact of a curved rigid surface (SFM3D4R, 38100 
elements) on one side of the tube. The vertical movement of 1 mm led the curved 





3.3.1. Multimodal Durability Test 
The number of scaffolds tested in each loading condition was summarized 
in Table VI. In all loading conditions, only one fracture was found in all 18 slot 
design scaffolds. It was at a connected peak (Type I) with a loading condition of 
bending and compression (no torsion). 
Table VI: Number of scaffolds being tested in each loading scenario 
 Total B+T+C B+C T+C B+T B only T only C only 
Non-Slot 25 7 3 3 3 3 3 3 
Slot 18 7 2 1 2 2 2 2 
 
Among all 25 non-slot designs, 43 fractures were found (Table VII). An 
average of 3.6, 2.7, 2.0, and 1.0 fractures per scaffold were found when B+T+C, 
B+C, T+C, and B+T, were applied, respectively. Only 1 fracture was found in all 9 
scaffolds tested with single mode of loading. In addition, fracture locations changed 
with loading modes (Table VII). No fractures were found at connectors (Type III) in 
all scenarios. In B+T+C cases, more than twice the number of fractures were Type 
1 (17) compared to Type 2 (8). When torsion was removed (B+C), there were still 
more Type I fractures, but the difference became smaller (Type I : Type II = 5 : 3). 
When compression was removed (B+T), more fractures were Type II (Type I : Type 




Table VII: Fractures in each loading scenario – Non-slot design 




3.6 2.7 2 1 0.3 0 0 
Type I 17 5 0 1 1 0 0 
Type II 8 3 6 2 0 0 0 
Type III No fracture found 
 
3.3.2. Pre-clinical Studies on Scaffold Fractures 
Two fractures, both Type I, were found in all 8 slot designs tested (0.25 
fractures per scaffold) while 54 fractures were found in 8 non-slot designs (6.75 
fractures per scaffold) after 30-day implantation. Among all 54 fractures in non-slot 
designs, the ratio of fractures at each location category was 2.2 : 1 : 0 (Type I : II : 
III). The location pattern in this animal study is highly consistent to benchtop 
B+T+C scenario results. 
3.3.3. FE Analysis on Stress Distribution Under Multimodal Loadings 
Stress concentrated at peak features in both designs after crimping, inflation, 
and with all loadings applied (Figure 15). Elements experiencing extreme stresses 
(> 150 MPa) were twice as much in the non-slot designs as in the slot designs. 
Maximum stress is higher in the slot designs (393 MPa) than in the non-slot 





Figure 15: Stress distribution in A) Non-slot and B) Slot designs. Stresses 
concentrated at peak features with more elements experiencing high stresses in 
non-slot designs than in slot designs.  
 
With different isolated loadings applied, stress concentrators changed 
(Figure 16). With bending applied, stress concentrated at connected peaks (Type 
I) (Figure 16A). With torsion applied, stress concentrators switched to unconnected 
peaks adjacent to connectors (Type II) (Figure 16B). With axial compression 
applied, stress concentrated at outer peak edges of connected peaks (Type I) 
(Figure 16C). In combined loading scenarios (Figure 17), when bending and 
compression were applied, stresses were concentrated more at connected peaks 
(Figure 17A). When bending and torsion were applied, stress concentrators started 
to switch to Type II, and when torsion and compression were applied, high stress 
points were all at Type II. Stress concentrators predicted here were consistent with 
fracture locations found in benchtop experiments at each loading scenarios. One 
thing to notice is that stresses generated by these cyclic loadings were much 
smaller compared to those caused by crimping and inflation. Stresses were mostly 
below 25 MPa with the highest around 40 MPa when bending was applied while 





Figure 16: Stress concentrators at isolated loading conditions. A) Bending: stress 
concentrated at inner peak edges of connected peaks (arrows). B) Torsion: stress 
concentrated at inner peak edges of unconnected peaks adjacent to connectors 
(arrows). C) Axial compression: stress concentrated at out peak edges of 
connected peaks (arrows)  
 
Figure 17: Stress concentrators at combined loading scenarios. A) Bending and 
Compression: stress concentrated more at connected peaks (Type I), followed by 
unconnected peaks adjacent to connectors (Type II) (arrows). B) Bending and 
Torsion: stress concentrated more at Type II (arrows). C) Torsion and 





Bioresorbable scaffolds are entailed to withstand tens of millions of cycles 
of multimodal loadings after implantation without any macroscopic structural 
failures until designated resorption phase starts. Thus, durability test is required by 
FDA 88 during product development phase to ensure safety. Current approach to 
seek out a qualified scaffold design is inherited from metal stents and heavily relies 
on trial and error. During early phase of product development, multiple design 
prototypes were created based on experiences from previous versions with slight 
modifications. Benchtop and animal tests were conducted to filter out unqualified 
designs, leaving one “qualified” design entering clinical trials, and bet on clinical 
studies to provide more insights and eventually gain FDA approval. However, this 
approach can oftentimes be misleading when benchtop and/or animal tests are not 
as robust and comprehensive as we believe. Current technical standards and 
regulatory requirements lack the understanding of patients’ vessel anatomy and 
dynamics, and lesion features, and thus failed to translate such information to 
particular benchtop setups. Traditional durability test, which applies single mode 
loading to simplified structures or whole scaffolds, often failed to identify any 
failures. This increases animal study costs dramatically and may lead researchers 
ignore potential failure modes. In addition, animal tests are often not adequate as 
analysis in healthy arteries has limited capabilities to mimic complex in vivo 
environment in real-world patients. The failures of the 1st generation BRS have 




Seven prototypes were created at Boston Scientific to go through traditional 
benchtop tests. For designs studied in this chapter, the slot and the non-slot design, 
almost no failures were identified. However, following animal tests which focused 
on comparing durability among different designs identified almost 7 fractures per 
scaffold in the non-slot design after 30-day implantation, while only 0.3 fracture per 
scaffold was found in the slot design. This gap again emphasizes the fact that 
current durability testing protocol is fundamentally flawed due to incorrectly 
integrating vessel geometries and dynamics.  
We developed a novel, high-throughput, multimodal test apparatus to apply 
isolated or combined cyclic axial compression, bending, and torsion deformation. 
The design incorporates mock arteries to enclose scaffolds. All loadings are 
transferred to the scaffold through the mock artery. This allows a more uniform 
application of compression and torsion along the length of the scaffold and 
prevents end damages caused by fixtures. A bending rod with a pre-defined 
curvature allows a more uniform application of bending moment along the length 
of the scaffold. The entire testing procedure mimic the implantation process in 
clinical practices to best and avoid undesirable mechanical input during specimen 
preparation. This system provides the ability to tightly reproduce the individual and 
combined deformation modes evident in arterial deformations in vivo, and it is 
flexible enough to accommodate for a wide range of deformation and scaffold 
dimensions. In addition, by modifying the mock artery, the system is able to 




Fatigue testing of scaffolds revealed that loading mode and scaffold design 
contribute to fracture initiation and propagation. Maximum stresses generated by 
cyclic loadings, i.e. bending, torsion, and axial compression, are not comparable 
to stresses generated during crimping and inflation, as the later induces a much 
higher strain on the scaffold (Figure 10 and 16). Most elements were even 
experiencing stresses within materials’ elastic regions when loadings were applied 
individually. This may indicate that the initiation of fracture is more likely due to the 
microstructural damages and micro-cracks induced by crimping and inflation, and 
these cracks may propagate into macroscopic failures when small but cyclic 
loadings are applied. 
Slots effectively reduced the number of fractures by acting as a crack 
propagation stopper. Although slot designs experienced similar or even higher 
stresses during crimping, inflation, and fatigue, than non-slot designs, less number 
of elements were experiencing extreme stresses in the former. In addition, high 
stressed elements were mostly concentrated around the slot features, especially 
at the small pieces linking the inner edges of the peak feature. This design releases 
high stresses by breaking itself and prevents micro-cracks from propagation 
through the entire strut.  
With loadings applied individually, almost no fracture was identified in both 
designs which confirmed again the fact that traditional benchtop testing strategies 




applied, fractures started to emerge (Table VII). In this way, the evaluation of 
scaffold durability becomes more robust and hidden design flaws can be identified 
before animal studies. In addition, variations in fracture locations were seen when 
different combinations of loadings were applied. The location pattern in benchtop 
tests and animal studies matches with all three loadings applied together. This is 
due to the changes in stress concentrators with different loading types (Figure 16) 
and indicates the possibility of predicting locations with high risk of fracture based 
on specific vessel geometries and dynamics. In addition, it shows the necessities 
to apply proper loading environment during benchtop testing in order to truly 
understand scaffolds’ structural integrity and durability. 
Performing the present work, we reemphasized that microstructural 
damages and micro-cracks should be considered as potential initiators of scaffold 
fracture. These deformations were caused by stress concentration and can be very 
well prevented through design optimization. However, this requires redefining the 
evaluation criteria for scaffold fracture. In addition, loading types contribute to crack 
propagation and determine fracture locations. Ignoring the necessity of 
incorporating a multi-modal loading environment into benchtop fatigue tests will 
lead to potential design defects undetected. In addition, with a thorough 
understanding of patient’s specific anatomy and lesion configurations combined 
with the robust benchtop testing apparatus we presented here, we may be able to 




CHAPTER FOUR: STRAIN-INDUCED ACCELERATED ASYMMETRIC 
SPATIAL DEGRADATION OF POLYMERIC VASCULAR SCAFFOLD 
4.1. Introduction 
Poly-l-lactic acid (pLLA) is the most commonly used material to make BRS 
by virtue of its mechanical strength, controllable degradation rate, and safe 
degradation products 67,89,90. It is a thermoplastic semi-crystalline polymer with a 
glass transition (Tg) and melting (Tm) temperature of about 55 oC and 175 oC, 
respectively 55. It is composed of lactic acids covalently linked into helical form 91. 
4.1.1. pLLA Degradation Mechanisms 
The degradation of pLLA in the body is a two-phase process: passive 
hydrolysis and active metabolism. Water penetrates into the material, attacks ester 
bonds in the polymer’s backbone, and converts long polymer chains into short 
water-soluble fragments. This process does not require the present of enzymes to 
catalyze the reaction, and is characterized as bulk degradation since water uptake 
into the polymer is faster than the rate of degradation. Then, these oligomers and 
monomers generated from hydrolysis will enter the citric acid cycle and are 
excreted as water and carbon dioxide (Figure 18) 55. For BRS, degradation through 
passive hydrolysis starts immediately after insertion, and thus affect its behaviors 
during its most critical duration. Factors controlling the degradation rate include 




Semi-crystalline polymers, such as pLLA, contain both amorphous regions 
where molecules are randomly oriented, and crystal regions where molecules are 
packed and aligned in certain directions. Amorphous regions degrade faster due 
to higher susceptible to hydration compared to crystalline regions 95. In addition, 
degradation is not a linear process. Progressive material alteration leads to 
changes in the local environment which in turn affects degradation. For example, 
with successive degradation, crystallinity of the polymer increases which makes it 
more resistant to hydrolysis than the initial formulation 95. On the other hand, when 
hydrolytic degradation byproducts with carboxylic end groups accumulate, local 
acidity rises and polymer degradation is accelerated 96. This explains why 
polymers with a wide molecular weight distribution (polydispersity index) and/or 
low molecular weight compared to high-molecular weight polymers, degrade faster 
for the latter have a greater number of carboxyl end groups.  
 
Figure 18: Hydrolysis of pLLA. Long chain pLLA is hydrolyzed by water attacking 
ester bonds in the backbone. Degradation products, lactic acids, will enter citric 




4.1.2. Quantification of Polymer Degradation  
The most frequently used parameter to describe polymer microstructures 
and monitor degradation is molecular weight (MW), which generally decreases as 
degradation proceeds. Other parameters such as mass loss, changes in 
crystallinity and/or thermal properties, pH changes in the degradation medium, 
formation of functional groups in the degrading products, and changes in the 
concentration of terminal groups have been used as well 97. Numerous techniques 
have also been reported. Gel permeation chromatography (GPC) and differential 
scanning calorimetry (DSC) are the most commonly used methods in quantifying 
molecular weight, crystallinity and changes in thermal properties 92. Yet, they are 
destructive, bulk methods and require an elevated number of samples. Scanning 
electron microscopy (SEM) and atomic force microscopy (AFM) are nondestructive 
methods but can only provide qualitative evaluation of degradation based on 
changes in polymer morphology. High performance liquid chromatography (HPLC) 
can detect the release of monomers in the solution but with limited detection 
resolution 98. Raman spectroscopy can be empirically, quantitatively and 
repeatedly used to measure molecular orientation, crystallinity and chemical 
composition with a resolution of 1 µm 99.  
Current benchtop degradation test required by FDA involves immersing 
samples in 37 oC PBS and tracking degradation at discrete time points until fully 




measured by GPC, DSC and weighing scales, respectively. The fabrication and 
implantation techniques for BRS are generally inherited from those employed for 
metal stents, which include tube extrusion and expansion, laser cutting, 
drug/polymer coating, crimping, sterilization, and deployment 100,101. Each step 
produces unique strain fields, which induce localized microstructural anisotropy, 
and may lead to changes in macroscopic performance, such as degradation rate 
and structural integrity 102. Thus, it is critical to characterize these microstructural 
anisotropies within devices in order to predict overall performances. However, 
such characterizations are often ignored during device design and testing due to 
limitations on the scale resolution of standard methods. Lack of such information 
produces unpredictable results in vivo.  
With Raman spectroscopy as a quantitative tool with microscale resolution, 
we quantified the distribution of molecular orientations and crystallinity within 
scaffolds. We identified spatial heterogeneities in microstructures within these 
devices. We compared two scaffold designs in terms of localized deformation 
induced flow disruption. We directly connected microscopic scaffold properties 
with macroscopic properties, and revealed that strain-induced heterogeneity in 
alignment and crystallinity leads to increased localized degradation and loss of 
structural integrity well before chemical processes can emerge and along a 




4.2. Materials and Methods 
4.2.1. Material Preparation 
pLLA resins, as-cut scaffolds, and fully resorbable pLLA scaffold systems 
(FRS) were provided by the Boston Scientific Corporation (Figure 3). Crimping was 
performed in air at room temperature on as-cut scaffolds. Inflation was performed 
in a 37 °C water bath within 30 seconds after immersion. 
 
4.2.2. Uniaxial Tensile Test on pLLA Sheet 
pLLA resins were dissolved in chloroform and solvent cast into a film with 
300 μm thickness at room temperature and pressure. The sheet was cut into 19×5 
mm rectangles, clamped onto two brass holders, and stretched to a 100% strain 
at 0.1 mm/s over 30 seconds using a tensile tester (Figure 19). The sheet was 
examined with polarized Raman spectroscopy to determine its molecular 






Figure 19: Experimental setup for uniaxial stretch of pLLA sheet. A) pLLA sheet 
was clamped onto two bronze plates and secured with screws. B) Clamps were 
attached to a biaxial tensile tester. The test was done at room temperature in air. 
 
 
4.2.3. Raman Spectroscopy 
A Raman spectrometer (Horiba LabRam 800HR) with a 514 nm argon laser 
was employed. The Raman scatter light was collected through a 100× objective 
lens, and the intensity was recorded using a CCD camera in the back scattering 
geometry. Calibration using silicone was done before any measurement. For 
quantifying %CR on solvent casting films, an area of 20 × 20 μm with 100 points 
was measured. Scaffolds were cut to expose the core. Three regions were 
examined for each scenario (e.g., OS, IS, and the core) and within each region, an 
area of 20 × 20 μm with 100 points was measured. For quantifying molecular 
orientation, polarized Raman spectroscopy was used with three different 
polarization geometries: Z(XX)Z, Z(XY)Z, and Z(YY)Z (Porto’s notation 103) and six 
replicated measurements were taken on each sample. The spectra were analyzed 




degree 3 polynomial function to all spectra before analysis. I875 was calculated by 
integrating from 825 to 900 cm−1. I1452 was calculated by integrating from 1425 to 
1500 cm−1. I925 was calculated by integrating from 910 to 930 cm−1.  
 
4.2.4. Crystallinity Calibration with DSC.  
Solvent-cast pLLA film was cut into several 1 cm × 1 cm squares and placed 
in an 80 °C oven for 0, 5, 10, 30, 60, and 120 mins. Percent crystallinity (%CR) 
was measured using a TA Instruments Q100 DSC after samples being examined 
by Raman spectroscopy. Samples were heated at 2 °C/min from 30 to 200 °C. The 
percent crystallinity was calculated with the equation 
%CR = [( 𝐻𝑚𝑒𝑙𝑡 − 𝐻𝑒𝑥𝑜𝑡ℎ𝑒𝑟𝑚 ) 93⁄ ] ∗ 100% 
where Hmelt is the area of the melt endotherm, Hexotherm is the area under the 
crystallization exotherm, and 93 J/g is the heat required to melt 100% crystalline 
pLLA 43. Two DSC measurements were done on each 1 cm by 1 cm square. 
 
4.2.5. Degradation Test on Scaffolds 
Scaffolds were inflated, mechanically cut and immersed in 37 oC PBS for 5, 
10, 20, 40, 90 and 110 days. PBS solution was changed every two days to ensure 




with Raman spectroscopy. Three categories of locations were measured including 
the extruded surfaces, pre-degradation cut and exposed core as a representative 
of laser cut surfaces (in direct contact with PBS when immersed), and the after-
degradation cut and exposed core (enclosed during immersion).  
 
4.2.6. Statistical Analyses 
Data are presented as mean ± standard deviation (SD) unless otherwise 
specified (n = 2 for DSC measurement; n = 100 and 300 for %CR measurement 
on pLLA films and scaffolds using Raman spectroscopy, respectively; n=6 for 
polarized Raman measurements on molecular orientation). Two-tail, unequal 
variance Student T-test were performed and a p-value < 0.05 was considered to 





4.3.1. Quantification of pLLA Orientation Using Polarized Raman Spectroscopy 
We examined clinical-grade BRS scaffolds and sheets of the same pLLA to 
define material orientation. pLLA polymer helical structure 91 can be represented 
with mc axis, defined as the molecular chain axis (Figure 20A). The integrated 
intensity of the Raman band at 875 cm−1 (I875, Figure 20B) represents the stretch 
mode of C-COO, the polymer backbone 99. As the polymer chain increases and 
becomes preferably aligned in one direction, the stretch of an extended backbone 
will result in an amplified signal in response to the incident polarized light, and thus 
I875 will also be stronger 104. During degradation, the cleavage of C-COO destroys 
the alignment of the polymer chain and reduces the synchronization of the stretch 
mode – accordingly, the corresponding Raman band intensity also falls. The 
integrated intensity of the Raman  and at 1452 cm−1 (I1452, Figure 20C) represents 
the asymmetric bending mode of CH3 99 which was considered as an internal 
standard during degradation 105,106.  
Solvent-casted pLLA sheets were stretched to a strain of 100% (Figure 20B), 
where the stretch axis was parallel to the polarization axis X. In the resting state 
sample, the intensity ratio (I875/I1452) with polarization geometry Z(XX)Z (based on 
Porto’s notation 103) is similar to that with Z(YY)Z (Figure 20C and D, higher with 
Z(YY)Z, but not statistically significant, P = 0.172). Thus, molecules in the pre-




pressure were more randomly oriented and isotropic compared with those of the 
after stretched sample. After stretch, molecules were aligned in the stretching 
direction (Figure 20D and E, P = 0.0075), supporting use of I875/I1452 as a marker 
for molecular orientation.  
 
Figure 20: Changes in molecular orientation identified with polarized Raman 
spectroscopy on stretched pLLA sheets. A) Molecular chain axis B) Pre- and after 
stretched pLLA sheet. C & E) Polarized Raman spectra of pre- and after stretched 
pLLA sheets from 800 to 1500 cm-1. D) Changes in intensity ratio with different 
polarization geometry: I875 / I1452 was not statistically different before being 
stretched (XX vs. YY, mean ± SD, 2.4 ± 0.10 vs. 2.6 ± 0.28, p = 0.172), and 
becomes much higher (XX vs. YY, mean ± SD, 3.4 ± 0.26 vs. 2.4 ± 0.18, p = 
0.0075) with Z(XX)Z compared to with Z(YY)Z after being stretched in the X 
direction. Based on Porto’s notation, XX and YY indicate that the polarization of 





4.3.2. Quantification of BRS Orientation Using Polarized Raman Spectroscopy  
Scaffolds were positioned with their axial direction (Figure 21A) parallel to 
the incident light polarization axis X (Figure 21B). The scaffold outer surface (OS, 
surface that contacts vessel walls), the inner surface (IS, surface that contacts 
luminal flow), and the core (the interior cross-section, Figure 21C) of as-cut 
scaffolds were examined with polarized Raman spectroscopy (Figure 21D).  
For the OS, IXX > IYY (intensity with polarization direction X and Y 
respectively, P < 0.001) indicating polymer strands are substantially more aligned 
in the axial direction. For the IS, IYY > IXX (P < 0.001), implying that molecules are 
aligned more toward the circumferential direction. For the core, the differences 
between the intensities of all three polarization geometries are much less 
significant compared with the surfaces, with the axial direction being the highest 
but not statistically significant (P = 0.124 for IXX and IRR). This implies that 
molecules in the core are more isotropically distributed. The boundary between the 
core and the surface is at least at about 1 μm below the surface, as that is the 
penetration depth of the laser. The immediate consequence of the observed 
heterogeneity in molecular orientation is the spatial heterogeneity in macroscopic 





Figure 21: Quantification of BRS orientation using polarized Raman spectroscopy. 
A) Scaffolds coordinates: A-C-R. B) Polarized Raman coordinates: Z is the 
direction of the incident light, X and Y are the polarization axes. C) Scaffolds were 
cut to expose the core and IS for Raman spectroscopy. D) IXX > IYY (mean ± SD, 
3.4 ± 0.17 vs. 2.2 ± 0.28, p < 0.001) on OS indicating molecules are aligned more 
toward the axial direction. IYY > IXX (mean ± SD, 2.3 ± 0.06 vs. 3.5 ± 0.10, p < 0.001) 
on IS indicates molecules are aligned more toward the circumferential direction. 
The core is more isotropic compared to the surfaces (IXX vs. IYY vs. IRR, mean ± SD, 
3.1 ± 0.08 vs. 2.8 ± 0.33 vs 2.6 ± 0.36, p = 0.124 and 0.146 when comparing IRR 
with IXX and IYY respectively). n = 6 for each scenario. 
 
In particular, crimping and re-inflation were investigated to determine their 
effects on molecular orientation. All edges were smooth in the as-cut samples 
(Figure 22A). Localized deformations were clearly visible at the inner peak edge 
after crimping (Figure 22B). After re-inflation, localized dimples were found at the 




cracks (Figure 22C). These locations correspond to regions predicted by FE 
analysis on a peak feature after crimping and re-inflation where high strain was 
experienced (Chapter 2, Figure 9). I875/I1452 with Z(XX)Z polarization geometry 
decreases (P = 0.04), indicating a disruption in the alignment of molecules and the 
achievement of an orientation-disordered polymer distribution (Figure 23). Thus, 
inhomogeneous, realistic strain fields disrupt the polymer molecular orientation, 
leading to an increase in the amorphous character of the polymer matrix.  
 
Figure 22: Crimping and re-inflation causing deformations and changes in 
molecular orientation. a) Straight edges after laser cut. b) Localized deformations 
were seen on the inner peak edges after crimping. c) Localized deformation (*) 
and micro-crack formation (→) happened at peak features after re-inflation.  
 
4.3.3. Quantification of BRS Crystallinity Using Raman Spectroscopy 
The integrated intensity of the Raman band at 925 cm−1 (CH3 rocking mode 
mixed with the stretch mode of the backbone)  was associated with the crystalline 




different crystallinity (%CR) verified by 
DSC (low %CR = 35%, high %CR = 
55%) where a stronger peak at 925 
cm−1 was observed in the high %CR 
sample. Using the Raman band at 1452 
cm−1 (CH3 as symmetric bending mode) 
taken as an internal normalization 
standard 105,106, the I925/I1452 ratio in 
relation with the nominal values of %CR 
were used to establish a direct 
correlation between the Raman spectra 
for any unknown sample (Figure 25A). 
The surfaces (both OS and IS, Figure 25B) show 61.1 ± 2.8% crystallinity, 
significantly higher than that of the core (38.3 ± 4.9%, P < 0.001). Such distinct 
difference in the crystal order, along with the molecular orientation, clearly 
indicates that areas with low %CR and isotropic molecular orientation may have 
significantly lower molecular density than other regions with high %CR and more 
anisotropic orientation. Such differentiation is the result of the thermal and 
mechanical strain history imparted during fabrication and implantation 42,102, and 
has significant effects on the macroscopic mechanical properties and the 
degradation rate 107,108.  
Figure 23: Changes in Raman intensity 
after crimping and inflation. I875 / I1452 
with Z(XX)Z polarization geometry 
decreases (mean ± SD, 3.4 ± 0.17 vs. 
3.2 ± 0.1, p = 0.04) at bend site (*) 
indicating a disruption in the alignment of 





Figure 24: Raman spectra of samples with different %CR: Low %CR = 35%, weak 





Figure 25: Quantification of %CR with Raman spectroscopy. A) Linear relationship 
between %CR determined by DSC and intensity ratio I925 / I1452 determined by 
Raman spectroscopy. B) %CR within BRS measured by Raman spectroscopy: 
significantly higher %CR (p < 0.001) on surfaces (mean ± SD, 61.6 ± 2.8%, blue, 
both OS and IS) compared to that in the core (mean ± SD, 38.3 ± 4.9%, red). n = 






4.3.4. Effects of Microstructure on Scaffold Degradation 
Spatial changes in %CR of BRS were examined after static immersion in 
37 °C PBS solution 69 for 5, 10, 20, 40, 90, 110, and 230 days using standard 
curves created above. The %CR on BRS extruded surface increased from 61.6 ± 
2.8% to 71.2 ± 2.6% (P < 0.001) in the first 10 days, remained unchanged at ∼70.2 
± 3.4% until 90 days, and decreased to 54.4% ± 2.1% at 230 days. The %CR in 
the pre-degradation cut core also increased first, from 38.3 ± 4.9% to 43.7 ± 3.5% 
in the first 5 days (P < 0.001), but then decreased to 29.3 ± 2.8% at 110 days. 
The %CR in the after-degradation cut core varied between 32.4% and 42.1% 
without a clear pattern (Figure 26A). Localized dimples found at peak features in 
the scaffold after crimping and re-inflation were further enlarged after degradation 
in 37 °C PBS for 3 months (Figure 26B&C). 
 
Figure 26: Heterogeneity in material properties leads to asymmetric degradation. 
A) Changes of %CR on extruded surfaces, pre-degradation cut core, and post 
degradation cut core. B) Light microscopic view on non-slot scaffolds after 3-month 
immersion in 37 oC PBS C) Scanning electron microscopy on slot scaffolds after 




The change in %CR during degradation can be described using the number 
of ester bonds per unit volume in crystalline region – [CR] and in amorphous region 




= −(𝑘1[𝐶𝑅]𝑒 +  𝑘2[𝐶𝑅]𝑒[𝑆𝐹]
𝑛) + 𝐶𝑅𝑒[𝐿𝐴]                           (1) 
𝑑[𝐿𝐴]
𝑑𝑡
= −(𝑘3[𝐿𝐴]𝑟 +  𝑘4[𝐿𝐴]𝑟[𝑆𝐹]









) + ∇ ∙ (𝐷∇[𝑆𝐹])                                     (3) 
The hydrolysis mechanisms being considered here include: noncatalytic 
hydrolysis where ester bonds are cleaved in the presence of water, autocatalytic 
hydrolysis where hydrolysis is catalyzed by the presence of carboxylic acid end 
groups, random scission where each ester bond in the polymer has an equal 
chance of chain cleavage, and end scission where only ester bonds at the end or 
polymer chains are cleaved. Water is assumed to be abundant and thus not shown 
in the equations. 𝑘1 and 𝑘3 are noncatalytic reaction constants and 𝑘2 and 𝑘4 are 
autocatalytic reaction constants. 𝐶𝑅𝑒 is the re-crystallization reaction constant. D is 
the diffusion coefficient. Subscripts e and r indicate end scission and random 





Changes in [CR] in Eq.1 is governed by end scission of ester bonds since 
crystalline phases strongly resist water penetration, and the re-crystallization of 
amorphous phases due to increased mobility from chain scission. Both 
noncatalytic and autocatalytic hydrolysis exist, where [SF] can be interpreted as 
the concentration of carboxylic acid end group which increases the rate of 
hydrolysis. The power n accounts for the dissociation of the acid end groups 109 
and is suggested to take the value of 0.5 110. Changes in [LA] in Eq.2 is governed 
by noncatalytic hydrolysis, autocatalytic hydrolysis, and re-crystallization. Both 
random and end scission exist. Changes in [SF] in Eq.3 is due to the degradation 
of both crystalline and amorphous phases, and the diffusion of oligomers governed 
by Fick’s law. D depends on the porosity and crystallinity of the polymer. 
The initial increase in %CR on the extruded surface is due to a combination 
of the diffusion of short fragments away from the scaffold and the re-crystallization 
of amorphous region caused by chain scission induced increased chain mobility 
109. This change in crystallinity makes the surface more resilient to hydrolysis than 
the initial formulation 95. Fast diffusion of oligomers on the surface prevents 
accumulation of carboxylic acid and thus minimizes the effect of autocatalytic 
hydrolysis. Faster degradation in the amorphous regions (a-pLLA) compared with 
crystalline regions (c-pLLA) due to greater water penetration 95 keeps the %CR at 
a high level until the c-pLLA started to degrade. The initial increase in %CR in the 
pre-degradation cut core is due to the same reason as the extruded surface while 




surface. This is mainly because the initial low %CR of the surface indicating higher 
porosity and less packed structure where longer fragments and even small 
crystalline regions can be washed away. Changes in %CR are different in the after-
degradation cut core. Due to the size of the device, short fragments cannot diffuse 
rapidly after generated. This leads to the accumulation of carboxylic acids and thus 
increased rate of auto-catalytic hydrolysis. The combination of the diffusion of short 
fragments, auto-catalytic hydrolysis, and re-crystallization of amorphous regions 
results in a balance in the changes of %CR.  
Fabrication-induced spatial differences in microstructures leads to different 
degradation rates (Figure 26). In addition, structural disruption at peak features in 
the scaffold that arises from applied strain from crimping and re-inflation also 
promoted the differentiation in microstructure (Figure 23). Furthermore, more 
significant differences in mechanical strength between the core and the surface 






Semi-crystalline polymer materials like pLLA contain different 
microstructural environments such as crystal domains and amorphous regions. 
Macroscopic properties like mechanical strength and material degradation highly 
depend on their microscopic structures such as molecular orientation and degree 
of crystallinity 107,111,112. Typically, increasing crystallinity or molecular orientation 
will reduce the rate of degradation and increase material stiffness but at the 
expense of ductility and fragility 111,112. The introduction of asymmetric spatial 
degradation calls for refinement of the classic paradigm of resorbable devices 113 
(Figure 27A) where scaffold support, material molecular weight, and device mass 
follow a homogeneous exponential decline. The expectation that material 
molecular weight changes and overall device mass loss follow a slow continuous 
course where support is maintained for significant time after implantation well 
beyond the time of vascular healing is no longer supportable. Asymmetric stresses 
create discontinuities in resorbable polymeric scaffold integrity far earlier than 
expected and even before chemical degradation (Figure 27B). When 
heterogeneous material properties impose asymmetric degradative forces on 
scaffold struts, mass loss is accelerated and a distribution of degradation emerges 
which alters the spatial balance of polymer alignment and crystallinity. Loss of 
support may be subtle at first and does not follow the abrupt discontinuity seen 
with metal stents, but is during the most vulnerable duration of tissue recovery 




is made even more noteworthy once surface crystallinity changes, which might 
adversely affect endothelial recovery and return of vascular function 43, further 
increasing clinical complications. Structural failures and resultant clinical 
implications arise from different mechanical events, on different scales and over 
different timeframes. One can now well envision how “weak links” in devices can 
emerge to cause stent failure far earlier than anticipated and why a balanced 
design must might account for these asymmetries. These issues take on specific 
urgency for endovascular implants operating in the highly dynamic coronary 
arterial environment, and in the face of 2 to 3-fold radial expansion at implantation, 
added cyclical strain from each heartbeat, and asymmetric recoil and bending 
forces 42. In BRS, the stakes are even higher for there is as well the dynamic of 
material degradation linked and matched to the time-evolving aspects of vascular 
healing. One can no longer expect that the material characteristics guarantee the 
resorbable scaffolds can maintain mechanical function well beyond vascular repair. 
There is likely loss of support even during the most critical times of healing and 
this may then explain in part the unexpected poor results of BVS (Abbott 
bioresorbable vascular scaffold) in clinical trials.  
Research strategies inherited from metallic stents focus on the evaluation 
of macrostructural integrity and prevention of abrupt loss due to fracture. Polymeric 
scaffolds, although rarely fracture, lose their structural integrity early and 
performance is dominated by microstructural dynamics. Raman spectroscopy 




spatial resolution, allowing us to directly identify and correlate the evolution of 
structural ordering in BRS upon strain application, and the effects on 
heterogeneous degradation. Significantly higher crystallinity (61.6 ± 2.8% vs. 38.3 
± 4.9%, P < 0.001) and higher molecular alignment were found on the surface of 
bioresorbable scaffolds after fabrication than in the core. During crimping and re-
inflation, the heterogeneous distribution of strain as dictated by scaffold 
morphology leads to localized changes in crystallinity and ordering, with an 
associated reduction in density. Such spatial heterogeneities inevitably produce 
and localize excess deformations at peak features (Figure 22). Micro-cracks 
initiated during crimping indicate potential failure sites which may propagate into 
macro-fractures after implantation under the influence of cyclical strain from the 
motion of the heart and asymmetric degradation. Dimple deformation initiated 
during re-inflation are therefore indicative of extreme structural irregularities under 
the influence of degradation. While most of the highly crystalline regions are 
preserved during strain applications, others undergo structural modifications from 
high-density crystalline to low-density amorphous, resulting in an enhanced and 
yet widely heterogeneous degradation. The highly crystalline surfaces of the 
scaffold could maintain the integrity of their microstructures after being degraded 
for more than 3 months. But, the low crystalline core of the scaffold experiences 
more substantial microstructural disruption with degradation (Figure 26) 
accelerated as early as 5 days after fluid contact, unable to maintain a stable 




The clinical consequences of such a sequence of events are profound. BRS 
scaffolds are expected to provide stable support for at least 6 months and longer, 
and homogeneously across the supported artery and lesion 42. Early loss of 
stability and uniformity can create the mismatches in alignment of scaffold and 
artery that we work so hard to avoid. Focal loss of structural integrity can enable 
greater recoil and malapposition of segments of the scaffold with critical effects on 
hemodynamics and healing. Protruding struts activate platelets, enable clot 
formation, delay re-endothelization, and could well be responsible for the high risk 
of thrombosis and myocardial infarction seen with BRS 43,46. 
Thermal and mechanical strain histories imparted during fabrication and 
implantation 105,112 have strong and dynamic effects on BRS scaffold 
microstructure, primarily manifest through the formation of microscale structural 
heterogeneities. From a materials perspective, we highlight that the strain on the 
microstructure in pLLA scaffolds directly affects the density of the material at the 
microscale, with enhanced degradation rates in as-fabricated as well as degraded 
low-crystalline, low-order regions. The materials-induced structural differentiation 
in degradation rates is primarily responsible for observed premature degradation 
potentially leading to unanticipated variability in bioresorbable device performance. 
The dynamic and heterogeneous nature of the structural composition not 
only provides added insight into potential mechanisms of clinical failures in BRS, 




class of devices and indeed all devices that make use of degradable materials and 
are subject to continued strain. Fabrication processes, therefore, should be 
carefully designed to prevent unexpected structural and functional failures. It might 
well be possible to create microstructure-enhanced polymer scaffolds whose 
strength matches current metal devices with comparable dimensions, limiting flow 
recirculation and nonuniform degradation and ultimately associated clinical 
complications. Controlled degradation through optimized materials and stent 
design might well result in BRS that are not only competitive with metal stents but 
overcome their limitations. For example, transitioning from a layered materials 
design structure (IS, core, OS) to a more homogeneous design would reduce the 
formation of faster degrading amorphous regions. Alternatively, engineering high 
strain regions of the scaffold out of highly crystalline pLLA would mitigate strain-
induced changes of the molecular structure toward a-pLLA, and therefore with a 
homogenization of the degradation rate across the full scaffold. In essence, the 
design processes should not only consider how the structural profile will affect 
macroscopic mechanical strength after implantation, but also should account for 
how the strain is distributed across the scaffold microstructure. Moreover, scaffolds 
should not be considered as homogeneous, like metal stents, in computational 
analyses simulating the mechanical and degradation performance 114–116. 
Nonuniform properties, such as differential molecular orientation and %CR, should 
be assigned to OS, IS, and the core of the device to achieve a more valid prediction 




we can now provide a more scientifically driven design and testing paradigm in the 
development of next-generation BRS specifically and devices of degradable 
materials in general.  
Figure 27 Theoretical life-span of BRS. A) Classic paradigm of BRS. MW, 
support, and mass follow a homogenous decline. B) Revised frame of BRS with 
asymmetric spatial degradation. Low alignment in the scaffold core and 
asymmetric structural stresses lead to asymmetric degradation which creates 
early discontinuities in support and far earlier mass loss. Re-endothelization and 
the return of vascular function are delayed. Loss of support is more noteworthy 
once the surface alignment changes as well. C) Clinical failure progression 
curve. High rate of clinical failures at acute/subacute time courses corresponds 
to the early loss in scaffold integrity due to asymmetric stresses. Failures slowly 
progress during Phase II when scaffold core starts to degrade during the most 
active duration of biological reaction. More failures start to emerge after 3-6 







CHAPTER FIVE: CONCLUSION AND FUTURE DIRECTIONS 
Bioresorbable scaffolds carried hope of revolutionizing cardiovascular 
interventions by providing comparable, short-term mechanical support seen with 
metal stents, and gradually degrade to eliminate long term complications. However, 
they failed dramatically with inferior clinical outcomes at all-time courses. This 
disappointment suggested that we might be using the wrong series of pre-clinical 
evaluation tools to study these devices as tests inherited from metal stents may 
not adequately define BRS. Indeed, we identified at least three areas where tests 
of metals cannot fully capture polymeric material performance: mechanics, 
durability, and degradation. BRS and like devices unlike their metal counterparts 
are far more sensitive to environmental conditions like immersion in liquid solutions, 
heat and stress and by definition degrade over the very time scale of testing. These 
fundamental differences between degradable polymers and durable metals require 
a thorough update on the evaluation system, otherwise we risk evaluation at wrong 
scales, timing, and locations. 
This dissertation project developed an integrated approach to study BRS 
which helped reveal the failure mechanisms of the 1st generation BRS, and provide 
insights in designing next generation BRS that might well be extended to all 





5.1. Mechanical Characterization and Peri-procedural Failures 
Our results (Chapter 2) confirmed the accepted notion that the rate of 
manufacturing/deployment phases (i.e. crimping/inflation) can potentially affect 
stress concentrations and risk of macroscopic fractures and recoil. Slower 
processes of induced shape change reduced adverse mechanical effects. The 
thresholds that distinguish rates – i.e. what is fast and what is slow are not 
universal. Specific material subsets behave differently and a priori knowledge of 
material properties is necessary to provide this context. These properties can be 
derived from a benchtop experiments and when not characterized for each specific 
device and environment condition may lead to a significant error in estimation of 
stress-induced damages and overestimation of benefits procedural updates might 
offer. Such error is further compounded by procedural variability. 
In addition, microstructural damages due to stress concentration, such as 
micro-cracks and localized deformations should complement macroscopic 
performance-assessment measures (fracture and recoil). Together they can alter 
local hemodynamics, already being disturbed by struts dimensions that are 
exaggerated in BRS given the need to account for weaker mechanical support of 
polymeric as opposed to metallic materials. Microcracks themselves then are 
extended by these added forces and more readily develop into fractures after cyclic 
multimodal loadings (Chapter 3). 




fascinating manner. The addition of a slot feature to the scaffold can potentially 
reduce stress concentration without sacrificing scaffold strength and flexibility. To 
precisely capture localized stress concentration and microstructural damages, 
context-related testing environment and clinically-relevant procedural scenarios 
should be devised in preliminary experiments of polymeric resorbable devices to 
enhance their efficacy and avoid unpredicted clinical events. 
 
5.2. Durability Characterization and Acute/Subacute Failures 
Scaffolds with certain design features tend to fracture more frequently at 
acute and subacute timeframes due to the propagation of micro-cracks generated 
during crimping and inflation process. This failure mode can easily be ignored if 
tested using current benchtop evaluation systems. To identify potential design 
defects and ensure structural integrity, it is necessary to apply physiological 
relevant loading environment when performing durability test. 
We found that fracture occur in predicable locations in patients when 
loading boundary conditions are known. All loadings types are required to best 
mimic in vivo fracture rate and location pattern. Both the strain mode and scaffold 
design contribute to fracture initiation and propagation. Adding a slot feature to the 
scaffold can effectively prevent fractures through reducing stress concentration, 




propagation stopper. However, the initiation of fracture happens even before 
implantation since the stress level generated during crimping and inflation are 
much higher in comparison to all cyclic loadings combined. 
 
5.3. Degradation Characterization and Late/Very Late Failures 
We demonstrated microstructural heterogeneities within BRS arising from 
integrated strain during fabrication and implantation using Raman spectroscopy. 
These differences in microstructure, e.g. crystallinity and polymer alignment, 
across scaffolds lead to faster degradation in laser-cut exposed cores than on the 
extruded surface, which enlarge localized deformation generated from crimping 
and inflation. These extreme structural irregularities and asymmetric material 
degradation will further disrupt local hemodynamics and thus bring inferior clinical 
performance.  
Unlike metal stents which stay patent and intact until catastrophic fracture, 
BRS exhibit loss of structural integrity almost immediately upon crimping and 
expansion. Irregularities in microstructure amplify these effects and can have 
profound clinical implications. Therefore, polymer microstructure should be 
considered in earliest design stages of resorbable devices, and fabrication 





5.4. Future Directions 
Our work has shed light on the underlying mechanisms causing the 
catastrophic failures of the 1st generation BRS and introduced new ways of 
optimizing and assessing future designs. With the set of tools developed in this 
work, we will be able to conduct further studies in understanding more 
comprehensively the interaction between the body and the implant device. 
As we already know that the three major coronary arteries, i.e. RCA, LCX, 
and LAD, have different geometries and dynamics. In addition, within the same 
major artery, the dynamics vary along the vessel. Therefore, to best accommodate 
complex vessel environment and provide safe and effective performances, specific 
features, instead of one universal design for all, should be considered based on 
the artery the scaffold serves. With advanced imaging techniques being developed 
nowadays, we are gaining deeper understanding on vessel geometries and 
dynamics. Thus, we can incorporate different combinations of loading types and 
magnitudes in aiding the selection of proper scaffolds for proper vessels. In 
addition, we will also be able to incorporate different lesion configurations to best 
mimic in vivo environment. 
In the space of degradation characterization, since mechanical stresses 
change materials’ degradation profile. It is critical to include physiological relevant 
loading environments when conducting degradation tests. Due to the complex 




work was only achieved with simplified geometry and loading conditions. Now, with 
the multimodal fatigue system and quantitative Raman spectroscopy, we will be 
able to generate a more realistic degradation profile. In addition, by taking into 
account the microstructural heterogeneities within the scaffolds, we can create a 
more robust degradation model and link it with scaffold mechanical performances. 
We hope that our findings will advance the dialogue surrounding 
bioresorbable scaffold design, development, and testing, and that this integrated 
approach will serve as a guideline for future analyses of device function and failure 
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